<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cef="http://xbrl.sec.gov/cef/2026"
  xmlns:ck0001379400="http://www.www.aberdeenaod.com/20260807"
  xmlns:dei="http://xbrl.sec.gov/dei/2026"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2026"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ck0001379400-20260807.xsd" xlink:type="simple"/>
    <context id="C_20260807to20260807_usgaapStatementClassOfStockAxis_ck0001379400PreferredSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001379400:PreferredSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-08-07</startDate>
            <endDate>2026-08-07</endDate>
        </period>
    </context>
    <context id="C_20260807to20260807">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
        </entity>
        <period>
            <startDate>2026-08-07</startDate>
            <endDate>2026-08-07</endDate>
        </period>
    </context>
    <context id="C_20260401to20260430_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001379400:CreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="C_20260430_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001379400:CreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="C_20251031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001379400:CreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-10-31</instant>
        </period>
    </context>
    <context id="C_20241031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001379400:CreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-31</instant>
        </period>
    </context>
    <context id="C_20231031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001379400:CreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="C_20221031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001379400:CreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="C_20211031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001379400:CreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="C_20201031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001379400:CreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="C_20181031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001379400:CreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-10-31</instant>
        </period>
    </context>
    <context id="C_20171031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001379400:CreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-10-31</instant>
        </period>
    </context>
    <context id="C_20161031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001379400:CreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-10-31</instant>
        </period>
    </context>
    <context id="C_20251001to20251031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001379400:CreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-10-01</startDate>
            <endDate>2025-10-31</endDate>
        </period>
    </context>
    <context id="C_20241001to20241031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001379400:CreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-10-31</endDate>
        </period>
    </context>
    <context id="C_20231001to20231031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001379400:CreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="C_20221001to20221031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001379400:CreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="C_20211001to20211031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001379400:CreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="C_20201001to20201031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001379400:CreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="C_20191001to20191031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001379400:CreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-01</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="C_20181001to20181031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001379400:CreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-01</startDate>
            <endDate>2018-10-31</endDate>
        </period>
    </context>
    <context id="C_20171001to20171031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001379400:CreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2017-10-31</endDate>
        </period>
    </context>
    <context id="C_20161001to20161031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001379400:CreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-10-01</startDate>
            <endDate>2016-10-31</endDate>
        </period>
    </context>
    <context id="C_20191031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ck0001379400:CreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-31</instant>
        </period>
    </context>
    <context id="C_20260807to20260807_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-08-07</startDate>
            <endDate>2026-08-07</endDate>
        </period>
    </context>
    <context id="C_20260807to20260807_usgaapStatementClassOfStockAxis_ck0001379400FeeForOpenMarketPurchasesOfCommonSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001379400:FeeForOpenMarketPurchasesOfCommonSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-08-07</startDate>
            <endDate>2026-08-07</endDate>
        </period>
    </context>
    <context id="C_20260807to20260807_usgaapStatementClassOfStockAxis_ck0001379400FeeForOptionalSharesPurchasesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001379400:FeeForOptionalSharesPurchasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-08-07</startDate>
            <endDate>2026-08-07</endDate>
        </period>
    </context>
    <context id="C_20260807to20260807_usgaapStatementClassOfStockAxis_ck0001379400SalesOfSharesHeldInDividendReinvestmentAccountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001379400:SalesOfSharesHeldInDividendReinvestmentAccountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-08-07</startDate>
            <endDate>2026-08-07</endDate>
        </period>
    </context>
    <context id="C_20251031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
        </entity>
        <period>
            <instant>2025-10-31</instant>
        </period>
    </context>
    <context id="C_20241031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
        </entity>
        <period>
            <instant>2024-10-31</instant>
        </period>
    </context>
    <context id="C_20231031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="C_20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="C_20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
        </entity>
        <period>
            <instant>2021-10-31</instant>
        </period>
    </context>
    <context id="C_20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
        </entity>
        <period>
            <instant>2019-10-31</instant>
        </period>
    </context>
    <context id="C_20181031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
        </entity>
        <period>
            <instant>2018-10-31</instant>
        </period>
    </context>
    <context id="C_20171031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
        </entity>
        <period>
            <instant>2017-10-31</instant>
        </period>
    </context>
    <context id="C_20161031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
        </entity>
        <period>
            <instant>2016-10-31</instant>
        </period>
    </context>
    <context id="C_20151031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
        </entity>
        <period>
            <instant>2015-10-31</instant>
        </period>
    </context>
    <context id="C_20251101to20260430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
        </entity>
        <period>
            <startDate>2025-11-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="C_20241101to20251031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
        </entity>
        <period>
            <startDate>2024-11-01</startDate>
            <endDate>2025-10-31</endDate>
        </period>
    </context>
    <context id="C_20231101to20241031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
        </entity>
        <period>
            <startDate>2023-11-01</startDate>
            <endDate>2024-10-31</endDate>
        </period>
    </context>
    <context id="C_20221101to20231031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="C_20211101to20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="C_20201101to20211031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2021-10-31</endDate>
        </period>
    </context>
    <context id="C_20191101to20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="C_20181101to20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
        </entity>
        <period>
            <startDate>2018-11-01</startDate>
            <endDate>2019-10-31</endDate>
        </period>
    </context>
    <context id="C_20171101to20181031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
        </entity>
        <period>
            <startDate>2017-11-01</startDate>
            <endDate>2018-10-31</endDate>
        </period>
    </context>
    <context id="C_20161101to20171031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
        </entity>
        <period>
            <startDate>2016-11-01</startDate>
            <endDate>2017-10-31</endDate>
        </period>
    </context>
    <context id="C_20151101to20161031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
        </entity>
        <period>
            <startDate>2015-11-01</startDate>
            <endDate>2016-10-31</endDate>
        </period>
    </context>
    <context id="C_20260430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
        </entity>
        <period>
            <instant>2026-04-30</instant>
        </period>
    </context>
    <context id="C_20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="C_20260803to20260803_usgaapStatementClassOfStockAxis_ck0001379400CommonSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ck0001379400:CommonSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-08-03</startDate>
            <endDate>2026-08-03</endDate>
        </period>
    </context>
    <context id="C_20260803to20260803">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
        </entity>
        <period>
            <startDate>2026-08-03</startDate>
            <endDate>2026-08-03</endDate>
        </period>
    </context>
    <context id="C_20260501to20260731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
        </entity>
        <period>
            <startDate>2026-05-01</startDate>
            <endDate>2026-07-31</endDate>
        </period>
    </context>
    <context id="C_20260201to20260430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
        </entity>
        <period>
            <startDate>2026-02-01</startDate>
            <endDate>2026-04-30</endDate>
        </period>
    </context>
    <context id="C_20251101to20260131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
        </entity>
        <period>
            <startDate>2025-11-01</startDate>
            <endDate>2026-01-31</endDate>
        </period>
    </context>
    <context id="C_20250801to20251031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
        </entity>
        <period>
            <startDate>2025-08-01</startDate>
            <endDate>2025-10-31</endDate>
        </period>
    </context>
    <context id="C_20250501to20250731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2025-07-31</endDate>
        </period>
    </context>
    <context id="C_20250201to20250430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
        </entity>
        <period>
            <startDate>2025-02-01</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="C_20241101to20250131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
        </entity>
        <period>
            <startDate>2024-11-01</startDate>
            <endDate>2025-01-31</endDate>
        </period>
    </context>
    <context id="C_20240801to20241031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
        </entity>
        <period>
            <startDate>2024-08-01</startDate>
            <endDate>2024-10-31</endDate>
        </period>
    </context>
    <context id="C_20240501to20240731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
        </entity>
        <period>
            <startDate>2024-05-01</startDate>
            <endDate>2024-07-31</endDate>
        </period>
    </context>
    <context id="C_20240201to20240430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
        </entity>
        <period>
            <startDate>2024-02-01</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="C_20231101to20240131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
        </entity>
        <period>
            <startDate>2023-11-01</startDate>
            <endDate>2024-01-31</endDate>
        </period>
    </context>
    <context id="C_20260803">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001379400</identifier>
        </entity>
        <period>
            <instant>2026-08-03</instant>
        </period>
    </context>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="SHARES">
        <measure>shares</measure>
    </unit>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Usd_per_Share">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807124851484">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityFileNumber
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807170326729">333-00000</dei:EntityFileNumber>
    <dei:EntityCentralIndexKey
      contextRef="C_20260807to20260807"
      id="Fdei_EntityCentralIndexKey20260807130844516">0001379400</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="C_20260807to20260807"
      id="Fdei_AmendmentFlag20260807130857421">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="C_20260807to20260807"
      id="Fdei_DocumentType20260807134102037">N-2ASR</dei:DocumentType>
    <dei:InvestmentCompanyActFileNumber
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807133812590">811-21980</dei:InvestmentCompanyActFileNumber>
    <dei:EntityInvCompanyType
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807120752552">N-2</dei:EntityInvCompanyType>
    <dei:DocumentRegistrationStatement
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807120848786">true</dei:DocumentRegistrationStatement>
    <dei:PreEffectiveAmendment
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807142205001">false</dei:PreEffectiveAmendment>
    <dei:PostEffectiveAmendment
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807142208386">false</dei:PostEffectiveAmendment>
    <dei:InvestmentCompanyActRegistration
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807121427168">true</dei:InvestmentCompanyActRegistration>
    <dei:EntityRegistrantName
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807122449030">abrdn Total Dynamic Dividend Fund</dei:EntityRegistrantName>
    <dei:EntityAddressAddressLine1
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807122803355">1900 Market Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807122807929">Suite 200</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807122815027">Philadelphia</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807145743994">PA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807122824056">19103</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807123404134">215</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807123411866">405-5700</dei:LocalPhoneNumber>
    <dei:ContactPersonnelName
      contextRef="C_20260807to20260807_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="Fxbrl_20260807123511993">Lucia Sitar, Esq.</dei:ContactPersonnelName>
    <dei:EntityAddressAddressLine1
      contextRef="C_20260807to20260807_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="Fxbrl_20260807123518033">1900 Market Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_20260807to20260807_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="Fxbrl_20260807123523506">Suite 200</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_20260807to20260807_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="Fxbrl_20260807123528991">Philadelphia</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_20260807to20260807_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="Fxbrl_20260807145757016">PA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_20260807to20260807_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="Fxbrl_20260807123545323">19103</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_20260807to20260807_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="Fxbrl_20260807123553191">215</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_20260807to20260807_deiEntityAddressesAddressTypeAxis_deiBusinessContactMember"
      id="Fxbrl_20260807123557289">405-5700</dei:LocalPhoneNumber>
    <dei:ApproximateDateOfCommencementOfProposedSaleToThePublic
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807124730084">From time to time after the effective date of this Registration Statement.</dei:ApproximateDateOfCommencementOfProposedSaleToThePublic>
    <dei:DividendOrInterestReinvestmentPlanOnly
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807124809174">false</dei:DividendOrInterestReinvestmentPlanOnly>
    <dei:DelayedOrContinuousOffering
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807124813144">true</dei:DelayedOrContinuousOffering>
    <cef:PrimaryShelfFlag
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807124815462">true</cef:PrimaryShelfFlag>
    <dei:EffectiveUponFiling462e
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807124822541">true</dei:EffectiveUponFiling462e>
    <dei:AdditionalSecuritiesEffective413b
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807124825485">false</dei:AdditionalSecuritiesEffective413b>
    <dei:EffectiveWhenDeclaredSection8c
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807124828197">false</dei:EffectiveWhenDeclaredSection8c>
    <dei:NewEffectiveDateForPreviousFiling
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807124830964">false</dei:NewEffectiveDateForPreviousFiling>
    <dei:AdditionalSecurities462b
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807124833588">false</dei:AdditionalSecurities462b>
    <dei:NoSubstantiveChanges462c
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807124835918">false</dei:NoSubstantiveChanges462c>
    <dei:ExhibitsOnly462d
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807124838893">false</dei:ExhibitsOnly462d>
    <cef:RegisteredClosedEndFundFlag
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807124841501">true</cef:RegisteredClosedEndFundFlag>
    <cef:BusinessDevelopmentCompanyFlag
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807124843501">false</cef:BusinessDevelopmentCompanyFlag>
    <cef:IntervalFundFlag
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807124846308">false</cef:IntervalFundFlag>
    <cef:PrimaryShelfQualifiedFlag
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807124849054">true</cef:PrimaryShelfQualifiedFlag>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807124854717">false</dei:EntityEmergingGrowthCompany>
    <cef:NewCefOrBdcRegistrantFlag
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807124900309">false</cef:NewCefOrBdcRegistrantFlag>
    <cef:PurposeOfFeeTableNoteTextBlock
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807120658297">
          &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The purpose of the following table and the example below is to help you understand the fees and expenses that holders of common shares of beneficial interest with no par value (&#x201c;Common Shares&#x201d;) (the &#x201c;Common Shareholders&#x201d;) would bear directly or indirectly. The expenses shown in the table under &#x201c;Other expenses&#x201d; are estimated for the Fund&#x2019;s current fiscal year ending October&#160;31, 2026. The expenses shown in the table under &#x201c;Interest expenses on bank borrowings&#x201d; and &#x201c;Total annual expenses&#x201d; are based on the Fund&#x2019;s capital structure as of April&#160;30, 2026.&#160;The table reflects Fund expenses as a percentage of net assets attributable to Common Shares.&lt;/p&gt;
        </cef:PurposeOfFeeTableNoteTextBlock>
    <cef:ShareholderTransactionExpensesTableTextBlock
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807120723707">
          &lt;div&gt;
            &lt;table cellpadding="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif;border-spacing:0px"&gt;
              
                &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;text-align:left"&gt;Common Shareholder transaction expenses&lt;/td&gt;
                  &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font-size:10pt;text-align:right"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom;background-color:White"&gt;
                  &lt;td style="width:81%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;Sales load (&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;as a percentage of offering price&lt;/span&gt;)(1)&lt;/td&gt;
                  &lt;td style="width:2%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:15%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;--&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;Offering expenses Borne by the Fund (as a percentage of offering price)(2)&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;--&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom;background-color:White"&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;Dividend reinvestment and optional cash purchase plan fees: (per share for open-market purchases of Common Shares)(3)&lt;/td&gt;
                  &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font-size:10pt;text-align:right"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font-size:10pt;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left;padding-left:10pt"&gt;Fee for Open Market Purchases of Common Shares&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;$0.02 (per share)&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom;background-color:White"&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left;padding-left:10pt"&gt;Fee for Optional Shares Purchases&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;$5.00 (max)&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                  &lt;td style="vertical-align:top;font:10pt Times New Roman, Times, Serif;text-align:left;padding-left:10pt"&gt;Sales of Shares Held in a Dividend Reinvestment Account&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;$0.12 (per share)&lt;br/&gt;and $25.00 (max)&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
              
            &lt;/table&gt;
          &lt;/div&gt;
        
          &lt;div&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
            &lt;div style="width:25%"&gt;
              &lt;div style="font-size:1pt;border-top:Black 1pt solid"&gt;&#160;&lt;/div&gt;
            &lt;/div&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;(1) If Common Shares are sold to or through underwriters, a prospectus supplement will set forth any applicable sales load and the estimated offering expenses borne by the Fund.&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;(2) Offering expenses payable by the Fund will be deducted from the proceeds, before expenses, to the Fund.&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;(3) Shareholders who participate in the Fund&#x2019;s Dividend Reinvestment and Optional Cash Purchase Plan (the &#x201c;Plan&#x201d;) may be subject to fees on certain transactions. The Plan Agent's (as defined under &#x201c;Dividend Reinvestment and Optional Cash Purchase Plan&#x201d; in this Prospectus) fees for the handling of the reinvestment of dividends will be paid by the Fund; however, participating shareholders will pay a $0.02 per share fee incurred in connection with open-market purchases in connection with the reinvestment of dividends, capital gains distributions and voluntary cash payments made by the participant, which will be deducted from the value of the dividend. For optional share purchases, shareholders will also be charged a $2.50 fee for automatic debits from a checking/savings account, a $5.00 one-time fee for online bank debit and/or $5.00 for check. Shareholders will be subject to $0.12 per share fee and either a $10.00 fee (for batch orders) or $25.00 fee (for market orders) for sales of shares held in a dividend reinvestment account. Per share fees include any applicable brokerage commissions the Plan agent is required to pay. For more details about the Plan, see &#x201c;Dividend Reinvestment and Optional Cash Purchase Plan&#x201d; in this Prospectus.&lt;/p&gt;
          &lt;/div&gt;
        </cef:ShareholderTransactionExpensesTableTextBlock>
    <cef:BasisOfTransactionFeesNoteTextBlock
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807120844021">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;as a percentage of offering price&lt;/span&gt;</cef:BasisOfTransactionFeesNoteTextBlock>
    <cef:SalesLoadPercent
      contextRef="C_20260807to20260807"
      decimals="2"
      id="Fxbrl_20260807121100687"
      unitRef="Pure">0</cef:SalesLoadPercent>
    <cef:UnderwritersCompensationPercent
      contextRef="C_20260807to20260807"
      decimals="2"
      id="Fxbrl_20260807121104578"
      unitRef="Pure">0</cef:UnderwritersCompensationPercent>
    <cef:DividendReinvestmentAndCashPurchaseFees
      contextRef="C_20260807to20260807_usgaapStatementClassOfStockAxis_ck0001379400FeeForOpenMarketPurchasesOfCommonSharesMember"
      decimals="2"
      id="Fxbrl_20260807121145562"
      unitRef="USD">0.02</cef:DividendReinvestmentAndCashPurchaseFees>
    <cef:DividendReinvestmentAndCashPurchaseFees
      contextRef="C_20260807to20260807_usgaapStatementClassOfStockAxis_ck0001379400FeeForOptionalSharesPurchasesMember"
      decimals="2"
      id="Fxbrl_20260807121149694"
      unitRef="USD">5</cef:DividendReinvestmentAndCashPurchaseFees>
    <cef:DividendReinvestmentAndCashPurchaseFees
      contextRef="C_20260807to20260807_usgaapStatementClassOfStockAxis_ck0001379400SalesOfSharesHeldInDividendReinvestmentAccountMember"
      decimals="2"
      id="Fxbrl_20260807121155059"
      unitRef="USD">0.12</cef:DividendReinvestmentAndCashPurchaseFees>
    <cef:OtherTransactionFeesBasisMaximum
      contextRef="C_20260807to20260807_usgaapStatementClassOfStockAxis_ck0001379400SalesOfSharesHeldInDividendReinvestmentAccountMember"
      decimals="2"
      id="Fxbrl_20260807121158593"
      unitRef="USD">25</cef:OtherTransactionFeesBasisMaximum>
    <cef:AnnualExpensesTableTextBlock
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807120810941">
          &lt;div&gt;
            &lt;table cellpadding="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif;border-spacing:0px"&gt;
              
                &lt;tr style="vertical-align:bottom"&gt;
                  &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;Annual&#160;expenses&lt;br/&gt;(as&#160;a&#160;percentage&#160;of&#160;net&#160;assets&lt;br/&gt;attributable&#160;to&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom"&gt;
                  &lt;td style="font-size:10pt"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;Common&#160;Shares)&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                  &lt;td style="width:76%;font:10pt Times New Roman, Times, Serif"&gt;Advisory fee(4)&lt;/td&gt;
                  &lt;td style="width:2%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:20%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;1.00&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom;background-color:White"&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;Interest expenses on bank borrowings(5)&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;0.02&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;Other expenses&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;0.19&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom;background-color:White"&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;Total annual expenses&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;1.21&lt;/td&gt;
                  &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;%&lt;/td&gt;
                &lt;/tr&gt;
              
            &lt;/table&gt;
          &lt;/div&gt;
        
          &lt;div&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;(4) The Adviser receives an annual investment advisory fee of 1.00% based on the Fund&#x2019;s average daily managed assets, computed daily and payable monthly. &#x201c;Managed Assets&#x201d; means total assets of the Fund, including any form of investment leverage, minus all accrued expenses incurred in the normal course of operations, but not excluding any liabilities or obligations attributable to investment leverage obtained through (i)&#160;indebtedness of any type (including, without limitation, borrowing through a credit facility or the issuance of debt securities), (ii)&#160;the issuance of preferred stock or other similar preference securities, (iii)&#160;the reinvestment of collateral received for securities loaned in accordance with the Fund&#x2019;s investment objectives and policies, and/or (iv)&#160;any other means.&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;(5) The percentage in the table is based on average total borrowings of $4,704,454 (the average balance outstanding under the Fund&#x2019;s secured, uncommitted line of credit with BNP Paribas Prime Brokerage International Ltd. (the &#x201c;Credit Facility&#x201d;) during the period ended April&#160;30, 2026, representing approximately 0.4% of the Fund&#x2019;s total average assets, which includes the assets purchased through leverage) and an average interest rate during the six months ended April&#160;30, 2026, of 4.82%. There can be no assurances that the Fund will be able to obtain such level of borrowing (or to maintain its current level of borrowing), that the terms under which the Fund borrows will not change, or that the Fund&#x2019;s use of leverage will be profitable. The Fund currently intends during the next twelve months to maintain a similar proportionate amount of borrowings but may increase such amount to 33 1/3% of the average daily value of the Fund&#x2019;s total assets.&lt;/p&gt;
          &lt;/div&gt;
        </cef:AnnualExpensesTableTextBlock>
    <cef:ManagementFeesPercent
      contextRef="C_20260807to20260807"
      decimals="4"
      id="Fxbrl_20260807121536666"
      unitRef="Pure">0.01</cef:ManagementFeesPercent>
    <cef:InterestExpensesOnBorrowingsPercent
      contextRef="C_20260807to20260807"
      decimals="4"
      id="Fxbrl_20260807121605354"
      unitRef="Pure">0.0002</cef:InterestExpensesOnBorrowingsPercent>
    <cef:OtherAnnualExpensesPercent
      contextRef="C_20260807to20260807"
      decimals="4"
      id="Fxbrl_20260807121638284"
      unitRef="Pure">0.0019</cef:OtherAnnualExpensesPercent>
    <cef:TotalAnnualExpensesPercent
      contextRef="C_20260807to20260807"
      decimals="4"
      id="Fxbrl_20260807121657984"
      unitRef="Pure">0.0121</cef:TotalAnnualExpensesPercent>
    <cef:ExpenseExampleTableTextBlock
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807121826984">
          &lt;div&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;Example&lt;/strong&gt;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The following example illustrates the expenses you would pay on a $1,000 investment in Common Shares, assuming a 5% annual portfolio total return.*&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
            &lt;table cellpadding="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif;border-spacing:0px"&gt;
              
                &lt;tr style="vertical-align:bottom"&gt;
                  &lt;td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;1&#160;Year&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;3&#160;Years&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;5&#160;Years&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                  &lt;td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;10&#160;Years&lt;/td&gt;
                  &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
                &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="width:22%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;12&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:2%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="width:22%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;38&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:2%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="width:21%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;66&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:2%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                  &lt;td style="width:21%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;147&lt;/td&gt;
                  &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                &lt;/tr&gt;
              
            &lt;/table&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;* The example does not include sales load or estimated offering costs. The example should not be considered a representation of future expenses or rate of return and actual Fund expenses may be greater or less than those shown. The example assumes that (i)&#160;all dividends and other distributions are reinvested at NAV, and (ii)&#160;the percentage amounts listed under &#x201c;Total annual expenses&#x201d; above remain the same in the years shown. For more complete descriptions of certain of the Fund&#x2019;s costs and expenses, see &#x201c;Management of the Fund &#x2014; Advisory Agreement.&#x201d;&lt;/p&gt;
          &lt;/div&gt;
        </cef:ExpenseExampleTableTextBlock>
    <cef:ExpenseExampleYear01
      contextRef="C_20260807to20260807"
      decimals="0"
      id="Fxbrl_20260807121836694"
      unitRef="USD">12</cef:ExpenseExampleYear01>
    <cef:ExpenseExampleYears1to3
      contextRef="C_20260807to20260807"
      decimals="0"
      id="Fxbrl_20260807121859155"
      unitRef="USD">38</cef:ExpenseExampleYears1to3>
    <cef:ExpenseExampleYears1to5
      contextRef="C_20260807to20260807"
      decimals="0"
      id="Fxbrl_20260807121901999"
      unitRef="USD">66</cef:ExpenseExampleYears1to5>
    <cef:ExpenseExampleYears1to10
      contextRef="C_20260807to20260807"
      decimals="0"
      id="Fxbrl_20260807121904682"
      unitRef="USD">147</cef:ExpenseExampleYears1to10>
    <us-gaap:NetAssetValuePerShare
      contextRef="C_20251031"
      decimals="2"
      id="Fxbrl_20260807132313193"
      unitRef="Usd_per_Share">10.05</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="C_20241031"
      decimals="2"
      id="Fxbrl_20260807133228067"
      unitRef="Usd_per_Share">9.65</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="C_20231031"
      decimals="2"
      id="Fxbrl_20260807133230859"
      unitRef="Usd_per_Share">8.54</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="C_20221031"
      decimals="2"
      id="Fxbrl_20260807133233581"
      unitRef="Usd_per_Share">8.61</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="C_20211031"
      decimals="2"
      id="Fxbrl_20260807133236731"
      unitRef="Usd_per_Share">10.98</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="C_20201031"
      decimals="2"
      id="Fxbrl_20260807145620607"
      unitRef="Usd_per_Share">8.76</us-gaap:NetAssetValuePerShare>
    <cef:AnnualDividendPayment
      contextRef="C_20251101to20260430"
      decimals="2"
      id="Fxbrl_20260807133453272"
      unitRef="Usd_per_Share">-0.61</cef:AnnualDividendPayment>
    <cef:AnnualDividendPayment
      contextRef="C_20241101to20251031"
      decimals="2"
      id="Fxbrl_20260807133513801"
      unitRef="Usd_per_Share">-1.17</cef:AnnualDividendPayment>
    <cef:AnnualDividendPayment
      contextRef="C_20231101to20241031"
      decimals="2"
      id="Fxbrl_20260807133516188"
      unitRef="Usd_per_Share">-0.82</cef:AnnualDividendPayment>
    <cef:AnnualDividendPayment
      contextRef="C_20221101to20231031"
      decimals="2"
      id="Fxbrl_20260807133518731"
      unitRef="Usd_per_Share">-0.69</cef:AnnualDividendPayment>
    <cef:AnnualDividendPayment
      contextRef="C_20211101to20221031"
      decimals="2"
      id="Fxbrl_20260807133521178"
      unitRef="Usd_per_Share">-0.69</cef:AnnualDividendPayment>
    <cef:AnnualDividendPayment
      contextRef="C_20201101to20211031"
      decimals="2"
      id="Fxbrl_20260807133523348"
      unitRef="Usd_per_Share">-0.69</cef:AnnualDividendPayment>
    <us-gaap:NetAssetValuePerShare
      contextRef="C_20260430"
      decimals="2"
      id="Fxbrl_20260807133644308"
      unitRef="Usd_per_Share">10.54</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="C_20251031"
      decimals="2"
      id="Fxbrl_20260807133635122_xbrl_20260807132313193"
      unitRef="Usd_per_Share">10.05</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="C_20241031"
      decimals="2"
      id="Fxbrl_20260807133635122_xbrl_20260807133228067"
      unitRef="Usd_per_Share">9.65</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="C_20231031"
      decimals="2"
      id="Fxbrl_20260807133635122_xbrl_20260807133230859"
      unitRef="Usd_per_Share">8.54</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="C_20221031"
      decimals="2"
      id="Fxbrl_20260807133635122_xbrl_20260807133233581"
      unitRef="Usd_per_Share">8.61</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="C_20211031"
      decimals="2"
      id="Fxbrl_20260807133635122_xbrl_20260807133236731"
      unitRef="Usd_per_Share">10.98</us-gaap:NetAssetValuePerShare>
    <us-gaap:SharePrice
      contextRef="C_20260430"
      decimals="2"
      id="Fxbrl_20260807133916328_xbrl_20260807133644308"
      unitRef="Usd_per_Share">10.18</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="C_20251031"
      decimals="2"
      id="Fxbrl_20260807133916328_xbrl_20260807133635122_xbrl_20260807132313193"
      unitRef="Usd_per_Share">9.59</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="C_20241031"
      decimals="2"
      id="Fxbrl_20260807133916328_xbrl_20260807133635122_xbrl_20260807133228067"
      unitRef="Usd_per_Share">8.75</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="C_20231031"
      decimals="2"
      id="Fxbrl_20260807133916328_xbrl_20260807133635122_xbrl_20260807133230859"
      unitRef="Usd_per_Share">7.26</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="C_20221031"
      decimals="2"
      id="Fxbrl_20260807133916328_xbrl_20260807133635122_xbrl_20260807133233581"
      unitRef="Usd_per_Share">7.5</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="C_20211031"
      decimals="2"
      id="Fxbrl_20260807133916328_xbrl_20260807133635122_xbrl_20260807133236731"
      unitRef="Usd_per_Share">10.05</us-gaap:SharePrice>
    <cef:SeniorSecuritiesAmt
      contextRef="C_20260430_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      decimals="-3"
      id="Fxbrl_20260807133946216_xbrl_20260807133644308"
      unitRef="USD">31919000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="C_20251031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      decimals="-3"
      id="Fxbrl_20260807133946216_xbrl_20260807133635122_xbrl_20260807132313193"
      unitRef="USD">8507000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="C_20241031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      decimals="-3"
      id="Fxbrl_20260807133946216_xbrl_20260807133635122_xbrl_20260807133228067"
      unitRef="USD">10460000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="C_20231031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      decimals="-3"
      id="Fxbrl_20260807133946216_xbrl_20260807133635122_xbrl_20260807133230859"
      unitRef="USD">49052000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="C_20221031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      decimals="-3"
      id="Fxbrl_20260807133946216_xbrl_20260807133635122_xbrl_20260807133233581"
      unitRef="USD">12250000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="C_20211031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      decimals="-3"
      id="Fxbrl_20260807133946216_xbrl_20260807133635122_xbrl_20260807133236731"
      unitRef="USD">4092000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="C_20260430_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      decimals="0"
      id="Fxbrl_20260807133948241_xbrl_20260807133644308"
      unitRef="Usd_per_Share">35829</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="C_20251031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      decimals="0"
      id="Fxbrl_20260807133948241_xbrl_20260807133635122_xbrl_20260807132313193"
      unitRef="Usd_per_Share">125550</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="C_20241031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      decimals="0"
      id="Fxbrl_20260807133948241_xbrl_20260807133635122_xbrl_20260807133228067"
      unitRef="Usd_per_Share">98308</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="C_20231031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      decimals="0"
      id="Fxbrl_20260807133948241_xbrl_20260807133635122_xbrl_20260807133230859"
      unitRef="Usd_per_Share">19353</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="C_20221031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      decimals="0"
      id="Fxbrl_20260807133948241_xbrl_20260807133635122_xbrl_20260807133233581"
      unitRef="Usd_per_Share">75124</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="C_20211031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      decimals="0"
      id="Fxbrl_20260807133948241_xbrl_20260807133635122_xbrl_20260807133236731"
      unitRef="Usd_per_Share">283852</cef:SeniorSecuritiesCvgPerUnit>
    <us-gaap:NetAssetValuePerShare
      contextRef="C_20191031"
      decimals="2"
      id="Fxbrl_20260807133246776"
      unitRef="Usd_per_Share">9.56</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="C_20181031"
      decimals="2"
      id="Fxbrl_20260807133249512"
      unitRef="Usd_per_Share">9.33</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="C_20171031"
      decimals="2"
      id="Fxbrl_20260807133254950"
      unitRef="Usd_per_Share">9.95</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="C_20161031"
      decimals="2"
      id="Fxbrl_20260807133257437"
      unitRef="Usd_per_Share">8.69</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="C_20151031"
      decimals="2"
      id="Fxbrl_20260807133259554"
      unitRef="Usd_per_Share">9.56</us-gaap:NetAssetValuePerShare>
    <cef:AnnualDividendPayment
      contextRef="C_20191101to20201031"
      decimals="2"
      id="Fxbrl_20260807133533329"
      unitRef="Usd_per_Share">-0.69</cef:AnnualDividendPayment>
    <cef:AnnualDividendPayment
      contextRef="C_20181101to20191031"
      decimals="2"
      id="Fxbrl_20260807133538352"
      unitRef="Usd_per_Share">-0.69</cef:AnnualDividendPayment>
    <cef:AnnualDividendPayment
      contextRef="C_20171101to20181031"
      decimals="2"
      id="Fxbrl_20260807133541876"
      unitRef="Usd_per_Share">-0.69</cef:AnnualDividendPayment>
    <cef:AnnualDividendPayment
      contextRef="C_20161101to20171031"
      decimals="2"
      id="Fxbrl_20260807133544246"
      unitRef="Usd_per_Share">-0.69</cef:AnnualDividendPayment>
    <cef:AnnualDividendPayment
      contextRef="C_20151101to20161031"
      decimals="2"
      id="Fxbrl_20260807133546612"
      unitRef="Usd_per_Share">-0.69</cef:AnnualDividendPayment>
    <us-gaap:NetAssetValuePerShare
      contextRef="C_20201031"
      decimals="2"
      id="Fxbrl_20260807145632326"
      unitRef="Usd_per_Share">8.76</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="C_20191031"
      decimals="2"
      id="Fxbrl_20260807133815453_xbrl_20260807133635122_xbrl_20260807133228067"
      unitRef="Usd_per_Share">9.56</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="C_20181031"
      decimals="2"
      id="Fxbrl_20260807133815453_xbrl_20260807133635122_xbrl_20260807133230859"
      unitRef="Usd_per_Share">9.33</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="C_20171031"
      decimals="2"
      id="Fxbrl_20260807133815453_xbrl_20260807133635122_xbrl_20260807133233581"
      unitRef="Usd_per_Share">9.95</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="C_20161031"
      decimals="2"
      id="Fxbrl_20260807133815453_xbrl_20260807133635122_xbrl_20260807133236731"
      unitRef="Usd_per_Share">8.69</us-gaap:NetAssetValuePerShare>
    <us-gaap:SharePrice
      contextRef="C_20201031"
      decimals="2"
      id="Fxbrl_20260807141419927_xbrl_20260807133916328_xbrl_20260807133635122_xbrl_20260807132313193"
      unitRef="Usd_per_Share">7.31</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="C_20191031"
      decimals="2"
      id="Fxbrl_20260807141419927_xbrl_20260807133916328_xbrl_20260807133635122_xbrl_20260807133228067"
      unitRef="Usd_per_Share">8.44</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="C_20181031"
      decimals="2"
      id="Fxbrl_20260807141419927_xbrl_20260807133916328_xbrl_20260807133635122_xbrl_20260807133230859"
      unitRef="Usd_per_Share">7.94</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="C_20171031"
      decimals="2"
      id="Fxbrl_20260807141419927_xbrl_20260807133916328_xbrl_20260807133635122_xbrl_20260807133233581"
      unitRef="Usd_per_Share">9.02</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="C_20161031"
      decimals="2"
      id="Fxbrl_20260807141419927_xbrl_20260807133916328_xbrl_20260807133635122_xbrl_20260807133236731"
      unitRef="Usd_per_Share">7.37</us-gaap:SharePrice>
    <cef:SeniorSecuritiesAmt
      contextRef="C_20201031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      decimals="-3"
      id="Fxbrl_20260807133935049_xbrl_20260807133635122_xbrl_20260807132313193"
      unitRef="USD">0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="C_20191031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      decimals="-3"
      id="Fxbrl_20260807133935049_xbrl_20260807133635122_xbrl_20260807133228067"
      unitRef="USD">0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="C_20181031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      decimals="-3"
      id="Fxbrl_20260807133935049_xbrl_20260807133635122_xbrl_20260807133230859"
      unitRef="USD">15401000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="C_20171031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      decimals="-3"
      id="Fxbrl_20260807133935049_xbrl_20260807133635122_xbrl_20260807133233581"
      unitRef="USD">33239000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAmt
      contextRef="C_20161031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      decimals="-3"
      id="Fxbrl_20260807133935049_xbrl_20260807133635122_xbrl_20260807133236731"
      unitRef="USD">0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="C_20201031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      decimals="0"
      id="Fxbrl_20260807133940175_xbrl_20260807133635122_xbrl_20260807132313193"
      unitRef="Usd_per_Share">0</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="C_20191031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      decimals="0"
      id="Fxbrl_20260807133940175_xbrl_20260807133635122_xbrl_20260807133228067"
      unitRef="Usd_per_Share">0</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="C_20181031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      decimals="0"
      id="Fxbrl_20260807133940175_xbrl_20260807133635122_xbrl_20260807133230859"
      unitRef="Usd_per_Share">65576</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="C_20171031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      decimals="0"
      id="Fxbrl_20260807133940175_xbrl_20260807133635122_xbrl_20260807133233581"
      unitRef="Usd_per_Share">31199</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesCvgPerUnit
      contextRef="C_20161031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      decimals="0"
      id="Fxbrl_20260807133940175_xbrl_20260807133635122_xbrl_20260807133236731"
      unitRef="Usd_per_Share">0</cef:SeniorSecuritiesCvgPerUnit>
    <cef:SeniorSecuritiesNoteTextBlock
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807122714015">
          &lt;div&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt;text-align:center"&gt;&lt;span id="ven_007"&gt;&lt;span style="text-transform:uppercase"&gt;&lt;strong&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Senior Securities&lt;/span&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The following table sets forth information about the Fund&#x2019;s outstanding senior securities as of the semi-annual period ended April&#160;30, 2026 and each of the Fund&#x2019;s last ten fiscal years. The Fund&#x2019;s senior securities during this time period are comprised of borrowings which constitutes a &#x201c;senior security&#x201d; as defined in the 1940 Act. Audited information regarding the Fund&#x2019;s senior securities for the last five fiscal years is incorporated by reference from the Fund&#x2019;s Financial Highlights included in the &lt;a href="https://www.sec.gov/Archives/edgar/data/1379400/000110465926002074/tm2528073d7_ncsr.htm"&gt;&lt;span style="color:Blue"&gt;Annual Report&lt;/span&gt;&lt;/a&gt;.&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
            
              &lt;div&gt;
                &lt;table cellpadding="0" style="border-collapse:collapse;width:80%;font:10pt Times New Roman, Times, Serif;margin-left:auto;margin-right:auto;border-spacing:0px"&gt;
                  
                    &lt;tr style="vertical-align:bottom"&gt;
                      &lt;td style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;Fiscal Year/Period&lt;br/&gt;Ended&lt;/td&gt;
                      &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;Title of Security&lt;/td&gt;
                      &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;strong&gt;Total Amount&lt;br/&gt;Outstanding&lt;br/&gt;(000 omitted)&lt;sup&gt;(1)&lt;/sup&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;strong&gt;Asset&lt;br/&gt;Coverage&lt;br/&gt;Per $1,000&lt;sup&gt;(2)&lt;/sup&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:15%"&gt;April&#160;30, 2026&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:2%"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:45%;text-align:left"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Credit Facility&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:2%"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"&gt;$&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:15%;text-align:right"&gt;31,919&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:2%"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"&gt;$&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:15%;text-align:right"&gt;35,929&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="vertical-align:bottom;background-color:White"&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;October&#160;31, 2025&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Credit Facility&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;8,507&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;125,550&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;October&#160;31, 2024&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Credit Facility&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10,460&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;98,308&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="vertical-align:bottom;background-color:White"&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;October&#160;31, 2023&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Credit Facility&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;49,052&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;19,353&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;October&#160;31, 2022&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Credit Facility&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;12,250&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;75,124&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="vertical-align:bottom;background-color:White"&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;October&#160;31, 2021&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Credit Facility&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;4,092&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;283,852&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;October&#160;31, 2020&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Credit Facility&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&#x2013;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&#x2013;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="vertical-align:bottom;background-color:White"&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;October&#160;31, 2019&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Credit Facility&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&#x2013;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&#x2013;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;October&#160;31, 2018&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Credit Facility&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;15,401&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;65,576&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="vertical-align:bottom;background-color:White"&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;October&#160;31, 2017&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Credit Facility&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;33,239&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;31,199&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;October&#160;31, 2016&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Credit Facility&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&#x2013;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&#x2013;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                  
                &lt;/table&gt;
                &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
                &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt;border-spacing:0px" width="100%"&gt;
                  
                    &lt;tr style="vertical-align:top"&gt;
                      &lt;td style="width:0.25in"&gt;&lt;/td&gt;
                      &lt;td style="width:0.25in"&gt;(1)&lt;/td&gt;
                      &lt;td&gt;Principal amount outstanding represents the principal amount owed by the Fund to lenders under the line of credit in place at the time.&lt;/td&gt;
                    &lt;/tr&gt;
                  
                &lt;/table&gt;
                &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt;border-spacing:0px" width="100%"&gt;
                  
                    &lt;tr style="vertical-align:top"&gt;
                      &lt;td style="width:0.25in"&gt;&lt;/td&gt;
                      &lt;td style="width:0.25in"&gt;(2)&lt;/td&gt;
                      &lt;td&gt;Asset coverage per $1,000 is calculated by dividing total&#160;assets (less all liabilities and indebtedness not represented by senior securities) by the amount of the line of credit outstanding and then multiplying by $1,000.&lt;/td&gt;
                    &lt;/tr&gt;
                  
                &lt;/table&gt;
              &lt;/div&gt;
            
          &lt;/div&gt;
        </cef:SeniorSecuritiesNoteTextBlock>
    <cef:SeniorSecuritiesHeadingsNoteTextBlock
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807164755501">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Senior Securities&lt;/span&gt;</cef:SeniorSecuritiesHeadingsNoteTextBlock>
    <cef:SeniorSecuritiesTableTextBlock
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807122832232">
              &lt;div&gt;
                &lt;table cellpadding="0" style="border-collapse:collapse;width:80%;font:10pt Times New Roman, Times, Serif;margin-left:auto;margin-right:auto;border-spacing:0px"&gt;
                  
                    &lt;tr style="vertical-align:bottom"&gt;
                      &lt;td style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;Fiscal Year/Period&lt;br/&gt;Ended&lt;/td&gt;
                      &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;Title of Security&lt;/td&gt;
                      &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;strong&gt;Total Amount&lt;br/&gt;Outstanding&lt;br/&gt;(000 omitted)&lt;sup&gt;(1)&lt;/sup&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;strong&gt;Asset&lt;br/&gt;Coverage&lt;br/&gt;Per $1,000&lt;sup&gt;(2)&lt;/sup&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:15%"&gt;April&#160;30, 2026&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:2%"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:45%;text-align:left"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Credit Facility&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:2%"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"&gt;$&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:15%;text-align:right"&gt;31,919&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:2%"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"&gt;$&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:15%;text-align:right"&gt;35,929&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="vertical-align:bottom;background-color:White"&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;October&#160;31, 2025&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Credit Facility&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;8,507&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;125,550&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;October&#160;31, 2024&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Credit Facility&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10,460&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;98,308&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="vertical-align:bottom;background-color:White"&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;October&#160;31, 2023&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Credit Facility&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;49,052&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;19,353&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;October&#160;31, 2022&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Credit Facility&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;12,250&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;75,124&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="vertical-align:bottom;background-color:White"&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;October&#160;31, 2021&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Credit Facility&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;4,092&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;283,852&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;October&#160;31, 2020&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Credit Facility&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&#x2013;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&#x2013;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="vertical-align:bottom;background-color:White"&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;October&#160;31, 2019&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Credit Facility&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&#x2013;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&#x2013;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;October&#160;31, 2018&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Credit Facility&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;15,401&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;65,576&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="vertical-align:bottom;background-color:White"&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;October&#160;31, 2017&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Credit Facility&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;33,239&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;31,199&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;October&#160;31, 2016&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Credit Facility&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&#x2013;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;$&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;&#x2013;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                  
                &lt;/table&gt;
                &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
                &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt;border-spacing:0px" width="100%"&gt;
                  
                    &lt;tr style="vertical-align:top"&gt;
                      &lt;td style="width:0.25in"&gt;&lt;/td&gt;
                      &lt;td style="width:0.25in"&gt;(1)&lt;/td&gt;
                      &lt;td&gt;Principal amount outstanding represents the principal amount owed by the Fund to lenders under the line of credit in place at the time.&lt;/td&gt;
                    &lt;/tr&gt;
                  
                &lt;/table&gt;
                &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt;border-spacing:0px" width="100%"&gt;
                  
                    &lt;tr style="vertical-align:top"&gt;
                      &lt;td style="width:0.25in"&gt;&lt;/td&gt;
                      &lt;td style="width:0.25in"&gt;(2)&lt;/td&gt;
                      &lt;td&gt;Asset coverage per $1,000 is calculated by dividing total&#160;assets (less all liabilities and indebtedness not represented by senior securities) by the amount of the line of credit outstanding and then multiplying by $1,000.&lt;/td&gt;
                    &lt;/tr&gt;
                  
                &lt;/table&gt;
              &lt;/div&gt;
            </cef:SeniorSecuritiesTableTextBlock>
    <cef:SecurityTitleTextBlock
      contextRef="C_20260401to20260430_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      id="Fxbrl_20260807123119219">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Credit Facility&lt;/span&gt;</cef:SecurityTitleTextBlock>
    <cef:SeniorSecuritiesAmt
      contextRef="C_20260430_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      decimals="-3"
      id="Fxbrl_20260807123749016"
      unitRef="USD">31919000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAverageMarketValuePerUnit
      contextRef="C_20260401to20260430_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      decimals="0"
      id="Fxbrl_20260807123800655"
      unitRef="Usd_per_Share">35929</cef:SeniorSecuritiesAverageMarketValuePerUnit>
    <cef:SecurityTitleTextBlock
      contextRef="C_20251001to20251031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      id="Fxbrl_20260807124328736">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Credit Facility&lt;/span&gt;</cef:SecurityTitleTextBlock>
    <cef:SeniorSecuritiesAmt
      contextRef="C_20251031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      decimals="-3"
      id="Fxbrl_20260807123853555"
      unitRef="USD">8507000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAverageMarketValuePerUnit
      contextRef="C_20251001to20251031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      decimals="0"
      id="Fxbrl_20260807123957392"
      unitRef="Usd_per_Share">125550</cef:SeniorSecuritiesAverageMarketValuePerUnit>
    <cef:SecurityTitleTextBlock
      contextRef="C_20241001to20241031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      id="Fxbrl_20260807124351378">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Credit Facility&lt;/span&gt;</cef:SecurityTitleTextBlock>
    <cef:SeniorSecuritiesAmt
      contextRef="C_20241031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      decimals="-3"
      id="Fxbrl_20260807123856018"
      unitRef="USD">10460000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAverageMarketValuePerUnit
      contextRef="C_20241001to20241031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      decimals="0"
      id="Fxbrl_20260807124000397"
      unitRef="Usd_per_Share">98308</cef:SeniorSecuritiesAverageMarketValuePerUnit>
    <cef:SecurityTitleTextBlock
      contextRef="C_20231001to20231031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      id="Fxbrl_20260807124413666">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Credit Facility&lt;/span&gt;</cef:SecurityTitleTextBlock>
    <cef:SeniorSecuritiesAmt
      contextRef="C_20231031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      decimals="-3"
      id="Fxbrl_20260807123858754"
      unitRef="USD">49052000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAverageMarketValuePerUnit
      contextRef="C_20231001to20231031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      decimals="0"
      id="Fxbrl_20260807124003005"
      unitRef="Usd_per_Share">19353</cef:SeniorSecuritiesAverageMarketValuePerUnit>
    <cef:SecurityTitleTextBlock
      contextRef="C_20221001to20221031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      id="Fxbrl_20260807125033380">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Credit Facility&lt;/span&gt;</cef:SecurityTitleTextBlock>
    <cef:SeniorSecuritiesAmt
      contextRef="C_20221031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      decimals="-3"
      id="Fxbrl_20260807123901695"
      unitRef="USD">12250000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAverageMarketValuePerUnit
      contextRef="C_20221001to20221031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      decimals="0"
      id="Fxbrl_20260807124005867"
      unitRef="Usd_per_Share">75124</cef:SeniorSecuritiesAverageMarketValuePerUnit>
    <cef:SecurityTitleTextBlock
      contextRef="C_20211001to20211031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      id="Fxbrl_20260807125055068">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Credit Facility&lt;/span&gt;</cef:SecurityTitleTextBlock>
    <cef:SeniorSecuritiesAmt
      contextRef="C_20211031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      decimals="-3"
      id="Fxbrl_20260807123904348"
      unitRef="USD">4092000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAverageMarketValuePerUnit
      contextRef="C_20211001to20211031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      decimals="0"
      id="Fxbrl_20260807124009416"
      unitRef="Usd_per_Share">283852</cef:SeniorSecuritiesAverageMarketValuePerUnit>
    <cef:SecurityTitleTextBlock
      contextRef="C_20201001to20201031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      id="Fxbrl_20260807125110871">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Credit Facility&lt;/span&gt;</cef:SecurityTitleTextBlock>
    <cef:SeniorSecuritiesAmt
      contextRef="C_20201031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      decimals="-3"
      id="Fxbrl_20260807123906989"
      unitRef="USD">0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAverageMarketValuePerUnit
      contextRef="C_20201001to20201031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      decimals="0"
      id="Fxbrl_20260807124012460"
      unitRef="Usd_per_Share">0</cef:SeniorSecuritiesAverageMarketValuePerUnit>
    <cef:SecurityTitleTextBlock
      contextRef="C_20191001to20191031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      id="Fxbrl_20260807125131708">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Credit Facility&lt;/span&gt;</cef:SecurityTitleTextBlock>
    <cef:SeniorSecuritiesAmt
      contextRef="C_20191031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      decimals="-3"
      id="Fxbrl_20260807125145440"
      unitRef="USD">0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAverageMarketValuePerUnit
      contextRef="C_20191001to20191031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      decimals="0"
      id="Fxbrl_20260807124015728"
      unitRef="Usd_per_Share">0</cef:SeniorSecuritiesAverageMarketValuePerUnit>
    <cef:SecurityTitleTextBlock
      contextRef="C_20181001to20181031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      id="Fxbrl_20260807125159552">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Credit Facility&lt;/span&gt;</cef:SecurityTitleTextBlock>
    <cef:SeniorSecuritiesAmt
      contextRef="C_20181031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      decimals="-3"
      id="Fxbrl_20260807123913456"
      unitRef="USD">15401000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAverageMarketValuePerUnit
      contextRef="C_20181001to20181031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      decimals="0"
      id="Fxbrl_20260807124019244"
      unitRef="Usd_per_Share">65576</cef:SeniorSecuritiesAverageMarketValuePerUnit>
    <cef:SecurityTitleTextBlock
      contextRef="C_20171001to20171031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      id="Fxbrl_20260807125210594">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Credit Facility&lt;/span&gt;</cef:SecurityTitleTextBlock>
    <cef:SeniorSecuritiesAmt
      contextRef="C_20171031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      decimals="-3"
      id="Fxbrl_20260807123920718"
      unitRef="USD">33239000</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAverageMarketValuePerUnit
      contextRef="C_20171001to20171031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      decimals="0"
      id="Fxbrl_20260807124022681"
      unitRef="Usd_per_Share">31199</cef:SeniorSecuritiesAverageMarketValuePerUnit>
    <cef:SecurityTitleTextBlock
      contextRef="C_20161001to20161031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      id="Fxbrl_20260807125241759">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Credit Facility&lt;/span&gt;</cef:SecurityTitleTextBlock>
    <cef:SeniorSecuritiesAmt
      contextRef="C_20161031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      decimals="-3"
      id="Fxbrl_20260807123925358"
      unitRef="USD">0</cef:SeniorSecuritiesAmt>
    <cef:SeniorSecuritiesAverageMarketValuePerUnit
      contextRef="C_20161001to20161031_usgaapDebtInstrumentAxis_ck0001379400CreditFacilityMember"
      decimals="0"
      id="Fxbrl_20260807124025301"
      unitRef="Usd_per_Share">0</cef:SeniorSecuritiesAverageMarketValuePerUnit>
    <cef:InvestmentObjectivesAndPracticesTextBlock
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807131215799">
      &lt;div&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"&gt;&lt;span id="ven_010"&gt;&lt;strong&gt;INVESTMENT OBJECTIVES AND POLICIES&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The information contained under the following headings in the Fund&#x2019;s &lt;a href="https://www.sec.gov/Archives/edgar/data/1379400/000110465926002074/tm2528073d7_ncsr.htm"&gt;&lt;span style="color:Blue"&gt;Annual Report&lt;/span&gt;&lt;/a&gt; are incorporated herein by reference: &#x201c;Additional Information Regarding the Fund&#x2014;Investment Objectives and Policies.&#x201d;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;PORTFOLIO TURNOVER&lt;/strong&gt;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The Fund&#x2019;s portfolio turnover rate may vary from year to year. A high portfolio turnover rate increases a fund&#x2019;s transaction costs (including brokerage commissions and dealer costs), which would adversely impact a fund&#x2019;s performance. Higher portfolio turnover may result in the realization of more short-term capital gains than if a fund had lower portfolio turnover.&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;INVESTMENT OBJECTIVES AND POLICIES&lt;/strong&gt;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The information contained under the heading &#x201c;Additional Information Regarding the Fund&#x2014;Investment Objectives and Policies&#x201d; in the Fund&#x2019;s &lt;a href="https://www.sec.gov/Archives/edgar/data/1379400/000110465926002074/tm2528073d7_ncsr.htm"&gt;&lt;span style="color:Blue"&gt;Annual Report&lt;/span&gt;&lt;/a&gt; is incorporated herein by reference.&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;PORTFOLIO INVESTMENTS&lt;/strong&gt;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The information contained under the heading &#x201c;Additional Information Regarding the Fund&#x2014;Portfolio Investments&#x201d; in the Fund&#x2019;s &lt;a href="https://www.sec.gov/Archives/edgar/data/1379400/000110465926002074/tm2528073d7_ncsr.htm"&gt;&lt;span style="color:Blue"&gt;Annual Report&lt;/span&gt;&lt;/a&gt; is incorporated herein by reference.&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;INVESTMENT TECHNIQUES&lt;/strong&gt;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The information contained under the heading &#x201c;Additional Information Regarding the Fund&#x2014;Investment Techniques&#x201d; in the Fund&#x2019;s &lt;a href="https://www.sec.gov/Archives/edgar/data/1379400/000110465926002074/tm2528073d7_ncsr.htm"&gt;&lt;span style="color:Blue"&gt;Annual Report&lt;/span&gt;&lt;/a&gt; is incorporated herein by reference.&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;USE OF LEVERAGE AND RELATED RISKS&lt;/strong&gt;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The information contained under the heading &#x201c;Additional Information Regarding the Fund&#x2014;Effects of Leverage&#x201d; in the Fund&#x2019;s &lt;a href="https://www.sec.gov/Archives/edgar/data/1379400/000110465926002074/tm2528073d7_ncsr.htm"&gt;&lt;span style="color:Blue"&gt;Annual Report&lt;/span&gt;&lt;/a&gt; is incorporated herein by reference.&lt;/p&gt;
      &lt;/div&gt;
    </cef:InvestmentObjectivesAndPracticesTextBlock>
    <cef:RiskFactorsTableTextBlock
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807132046007">
      &lt;div&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"&gt;&lt;span id="ven_011"&gt;&lt;span style="text-transform:uppercase"&gt;&lt;strong&gt;Risk factors&lt;/strong&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The information contained under the heading &#x201c;Additional Information Regarding the Fund&#x2014;Risk Factors&#x201d; in the Fund&#x2019;s &lt;a href="https://www.sec.gov/Archives/edgar/data/1379400/000110465926002074/tm2528073d7_ncsr.htm"&gt;&lt;span style="color:Blue"&gt;Annual Report&lt;/span&gt;&lt;/a&gt; is incorporated herein by reference. Investors should consider the specific risk factors and special considerations associated with investing in the Fund. An investment in the Fund is subject to investment risk, including the possible loss of your entire investment.&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;A Prospectus Supplement relating to an offering of the Fund&#x2019;s securities may identify additional risk associated with such offering.&lt;/p&gt;
      &lt;/div&gt;
    </cef:RiskFactorsTableTextBlock>
    <cef:CapitalStockTableTextBlock
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807124302707">
          &lt;div style="font-size:10pt;font-family:Times New Roman"&gt;
            &lt;div&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"&gt;&lt;span id="ven_019"&gt;&lt;strong&gt;DESCRIPTION OF CAPITAL STRUCTURE&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The Fund is a statutory trust organized under the laws of the State of Delaware pursuant to the Agreement and Declaration of Trust dated as of October&#160;27, 2006. The Fund is authorized to issue an unlimited number of common shares of beneficial interest no par value. The Fund intends to hold annual meetings of shareholders so long as the Common Shares are listed on a national securities exchange and such meetings are required as a condition to such listing.&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;GENERAL&lt;/strong&gt;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;Set forth below is information with respect to the Fund&#x2019;s outstanding securities as of August&#160;3, 2026:&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              
                &lt;table cellpadding="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif;border-spacing:0px"&gt;
                  
                    &lt;tr style="vertical-align:bottom"&gt;
                      &lt;td style="font:bold 10pt Times New Roman, Times, Serif;border-bottom:Black 1pt solid"&gt;Title&#160;of&#160;Class&lt;/td&gt;
                      &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;Amount&lt;br/&gt;Authorized&lt;/td&gt;
                      &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;Amount&#160;Held&#160;by&lt;br/&gt;the&#160;Fund&#160;or&#160;for&#160;its&lt;br/&gt;Account&lt;/td&gt;
                      &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;Amount&#160;Outstanding&lt;br/&gt;Exclusive&#160;of&#160;Common&lt;br/&gt;Shares&#160;Held&#160;by&#160;the&#160;Fund&lt;br/&gt;or&#160;for&#160;its&#160;Own&#160;Account&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                      &lt;td style="width:58%;font:10pt Times New Roman, Times, Serif;text-align:center"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Common Shares&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="width:2%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:12%;font:10pt Times New Roman, Times, Serif;text-align:center"&gt;Unlimited&lt;/td&gt;
                      &lt;td style="width:2%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;0&lt;/td&gt;
                      &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:2%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:12%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;105,466,347&lt;/td&gt;
                    &lt;/tr&gt;
                  
                &lt;/table&gt;
              
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;Except to the extent required for a Delaware business corporation, the Shareholders shall have no power to vote as to whether or not a court action, legal proceeding or claim should or should not be brought or maintained derivatively or as a class action on behalf of the Trust or the Shareholders. These requirements will not apply to claims brought under the federal securities laws.&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;COMMON SHARES&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The Agreement and Declaration of Trust permits the Fund to issue an unlimited number of full and fractional Common Shares of beneficial interest, no par value. Each share of the Fund represents an equal proportionate interest in the assets of the Fund with each other share in the Fund. Holders of Common Shares will be entitled to the payment of dividends when, as and if declared by the Board. The Fund intends to make a level dividend distribution each month to its shareholders after payment of fund operating expenses including interest on outstanding borrowings, if any. Unless the registered owner of Common Shares elects to receive cash, all dividends declared on Common Shares (net of applicable withholding) will be automatically reinvested (net of applicable withholding tax) for shareholders in additional Common Shares of the Fund. See &#x201c;Dividend Reinvestment and Optional Cash Purchase Plan.&#x201d; &lt;span style="font-size:10pt;font-family:Times New Roman"&gt;The 1940 Act or the terms of any borrowings may limit the payment of dividends to the holders of Common Shares.&lt;/span&gt; &lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Each whole share shall be entitled to one vote as to matters on which it is entitled to vote pursuant to the terms of the Agreement and Declaration of Trust on file with the SEC.&lt;/span&gt; &lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Upon liquidation of the Fund, after paying or adequately providing for the payment of all liabilities of the Fund, and upon receipt of such releases, indemnities and refunding agreements as they deem necessary for their protection, the Trustees may distribute the remaining managed assets of the Fund among its shareholders.&lt;/span&gt; The shares are not liable to further calls or to assessment by the Fund. &lt;span style="font-size:10pt;font-family:Times New Roman"&gt;There are no pre-emptive rights associated with the shares.&lt;/span&gt; &lt;span style="font-size:10pt;font-family:Times New Roman"&gt;The Agreement and Declaration of Trust provides that the Fund&#x2019;s shareholders are not liable for any liabilities of the Fund.&lt;/span&gt; Although shareholders of an unincorporated statutory trust established under Delaware law, in certain limited circumstances, may be held personally liable for the obligations of the Fund as though they were general partners, the provisions of the Agreement and Declaration of Trust described in the foregoing sentence make the likelihood of such personal liability remote. The Fund generally will not issue share certificates.&lt;/p&gt;
            &lt;/div&gt;
          &lt;/div&gt;
        
            &lt;div&gt;&#160;&lt;/div&gt;
          
          &lt;div&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;In general, when there are any borrowings, including reverse repurchase agreements that are counted as indebtedness, or preferred shares and/or notes outstanding, the Fund may not be permitted to declare any cash distribution on its Common Shares, unless at the time of such declaration, (i)&#160;all accrued distributions on preferred shares or accrued interest on borrowings have been paid and (ii)&#160;the value of the Fund&#x2019;s total assets (determined after deducting the amount of such distribution), less all liabilities and indebtedness of the Fund not represented by senior securities, is at least 300% of the aggregate amount of such securities representing indebtedness and at least 200% of the aggregate amount of securities representing indebtedness plus the aggregate liquidation value of the outstanding preferred shares (expected to equal the aggregate original purchase price of the outstanding preferred shares plus the applicable redemption premium, if any, together with any accrued and unpaid distributions thereon, whether or not earned or declared and on a cumulative basis). In addition to the requirements of the 1940 Act, the Fund may be required to comply with other asset coverage requirements as a condition of the Fund obtaining a rating of the preferred shares or notes from a NRSRO. These requirements may include an asset coverage test more stringent than under the 1940 Act. This limitation on the Fund&#x2019;s ability to make distributions on its Common Shares could in certain circumstances impair the ability of the Fund to maintain its qualification for taxation as a regulated investment company for federal income tax purposes. The Fund intends, however, to the extent possible to purchase or redeem preferred shares or notes or reduce borrowings from time to time to maintain compliance with such asset coverage requirements and may pay special distributions to the holders of the preferred shares in certain circumstances in connection with any such impairment of the Fund&#x2019;s status as a regulated investment company. See &#x201c;Distributions.&#x201d; Depending on the timing of any such redemption or repayment, the Fund may be required to pay a premium in addition to the liquidation preference of the preferred shares to the holders thereof.&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The trading or &#x201c;ticker&#x201d; symbol of the Common Shares on the NYSE is &#x201c;AOD.&#x201d;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;strong&gt;&lt;i&gt;Common Share Price Data&lt;/i&gt;&lt;/strong&gt;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The Fund&#x2019;s Common Shares are publicly held and are listed and traded on the NYSE. The following table sets forth for the fiscal quarters indicated the highest and lowest daily prices during the applicable quarter at the close of market on the NYSE per Common Share along with (i)&#160;the highest and lowest closing NAV and (ii)&#160;the highest and lowest premium or discount from NAV represented by such prices at the close of the market on the NYSE.&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
            
              &lt;div&gt;
                &lt;table cellpadding="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif;border-spacing:0px"&gt;
                  
                    &lt;tr style="vertical-align:bottom"&gt;
                      &lt;td style="font-size:10pt;text-align:center"&gt;&#160;&lt;/td&gt;
                      &lt;td style="text-align:center;font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="6" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;strong&gt;NYSE Market Price&lt;sup&gt;(1)&lt;/sup&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:center;padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="text-align:center;font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="6" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;strong&gt;NAV at NYSE Market Price&lt;sup&gt;(1)&lt;/sup&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:center;padding-bottom:1pt;font-size:10pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="text-align:center;font-size:10pt;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="6" style="border-bottom:Black 1pt solid;font-size:10pt;text-align:center"&gt;&lt;strong&gt;Market Premium/(Discount) to NAV on Date of NYSE Market Price&lt;sup&gt;(1)&lt;/sup&gt;&lt;/strong&gt;&lt;/td&gt;
                      &lt;td style="text-align:center;padding-bottom:1pt;font-size:10pt"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="vertical-align:bottom"&gt;
                      &lt;td style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;strong&gt;Quarter Ended&lt;sup&gt;(2)&lt;/sup&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="padding-bottom:1pt;text-align:center;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;High&lt;/td&gt;
                      &lt;td style="padding-bottom:1pt;text-align:center;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="padding-bottom:1pt;text-align:center;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;Low&lt;/td&gt;
                      &lt;td style="padding-bottom:1pt;text-align:center;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="padding-bottom:1pt;text-align:center;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;High&lt;/td&gt;
                      &lt;td style="padding-bottom:1pt;text-align:center;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="padding-bottom:1pt;text-align:center;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;Low&lt;/td&gt;
                      &lt;td style="padding-bottom:1pt;text-align:center;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="padding-bottom:1pt;text-align:center;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;High&lt;/td&gt;
                      &lt;td style="padding-bottom:1pt;text-align:center;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="padding-bottom:1pt;text-align:center;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;Low&lt;/td&gt;
                      &lt;td style="padding-bottom:1pt;text-align:center;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                      &lt;td style="width:16%;font:10pt Times New Roman, Times, Serif;text-align:center;padding-bottom:1pt"&gt;July&#160;31, 2026&lt;/td&gt;
                      &lt;td style="width:2%;font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:10%;text-align:right"&gt;10.63&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:2%;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:10%;text-align:right"&gt;10.06&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:2%;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:10%;text-align:right"&gt;10.90&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:2%;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:10%;text-align:right"&gt;10.43&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:2%;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:10%;text-align:right"&gt;(2.48&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;padding-bottom:1pt;text-align:left"&gt;)%&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:2%;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:10%;text-align:right"&gt;(3.55&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;padding-bottom:1pt;text-align:left"&gt;)%&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="vertical-align:bottom;background-color:White"&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:center;padding-bottom:1pt"&gt;April&#160;30, 2026&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10.70&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;8.81&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10.63&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;9.60&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(0.66&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;)%&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(8.23&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;)%&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:center;padding-bottom:1pt"&gt;January&#160;31, 2026&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10.13&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;9.20&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10.42&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;9.92&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(2.78&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;)%&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(7.26&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;)%&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="vertical-align:bottom;background-color:White"&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:center"&gt;October&#160;31, 2025&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;9.74&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;8.80&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10.14&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;9.44&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(3.94&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(6.78&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:center;padding-bottom:1pt"&gt;July&#160;31, 2025&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;9.12&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;8.29&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;9.89&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;9.17&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(7.79&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;)%&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(9.60&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;)%&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="vertical-align:bottom;background-color:White"&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:center;padding-bottom:1pt"&gt;April&#160;30, 2025&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;8.86&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;7.42&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;9.76&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;8.36&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(9.22&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;)%&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(11.24&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;)%&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:center;padding-bottom:1pt"&gt;January&#160;31, 2025&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;8.89&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;8.36&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;9.79&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;9.42&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(9.19&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;)%&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(11.25&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;)%&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="vertical-align:bottom;background-color:White"&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:center;padding-bottom:1pt"&gt;October&#160;31, 2024&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;9.10&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;8.03&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10.10&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;9.38&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(9.90&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;)%&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(14.39&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;)%&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:center;padding-bottom:1pt"&gt;July&#160;31, 2024&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;8.72&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;8.00&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10.09&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;9.32&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(13.58&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;)%&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(14.16&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;)%&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="vertical-align:bottom;background-color:White"&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:center;padding-bottom:1pt"&gt;April&#160;30, 2024&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;8.29&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;7.78&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;9.69&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;9.27&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(14.45&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;)%&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(16.07&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;)%&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:center;padding-bottom:1pt"&gt;January&#160;31, 2024&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;8.12&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;7.31&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;9.62&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;8.61&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(15.59&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;)%&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(15.10&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;)%&lt;/td&gt;
                    &lt;/tr&gt;
                  
                &lt;/table&gt;
                &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
                &lt;div style="width:25%"&gt;
                  &lt;div style="font-size:1pt;border-top:Black 1pt solid"&gt;&#160;&lt;/div&gt;
                &lt;/div&gt;
                &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 0.25in;text-indent:-0.25in"&gt;(1)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Source: Bloomberg L.P.&lt;/p&gt;
                &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 0.25in;text-indent:-0.25in"&gt;(2)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Data presented are with respect to a short period of time and are not indicative of future performance.&lt;/p&gt;
              &lt;/div&gt;
            
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
            &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;Shares of closed-end management investment companies may trade at a market price that is less than the NAV that is attributable to those shares. The possibility that the Fund&#x2019;s Common Shares will trade at a discount to NAV or at a premium that is unsustainable over the long term is separate and distinct from the risk that the Fund&#x2019;s NAV will decrease. It is not possible to predict whether the Fund&#x2019;s Common Shares will trade at, above or below NAV in the future. On August&#160;3, 2026, the Fund&#x2019;s NAV was $10.57, and the last reported sale price of a Common Share on the NYSE was $10.50, representing a discount to NAV of -0.66%.&lt;/p&gt;
          &lt;/div&gt;
        
            &lt;div&gt;&#160;&lt;/div&gt;
          
            &lt;div&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;OPEN MARKET SHARE REPURCHASE PROGRAM&lt;/strong&gt;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The Fund&#x2019;s Board approved an open market share repurchase program (the &#x201c;Program&#x201d;). The Program allows the Fund to purchase, in the open market, its outstanding Common Shares, with the amount and timing of any repurchase determined at the discretion of the Fund's investment adviser. Such purchases may be made opportunistically at certain discounts to NAV per share in the reasonable judgment of management based on historical discount levels and current market conditions.&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;On a quarterly basis, the Fund&#x2019;s Board will receive information on any transactions made pursuant to this policy during the prior quarter and if shares are repurchased management will post the number of shares repurchased on the Fund's&#160;website on a monthly basis.&#160; Under the terms of the Program, the Fund is permitted to repurchase up to 10% of its outstanding Common Shares in the open market during any 12 month period. There can be no assurance, however, that the Board will decide to undertake any of these actions or that, if undertaken, such actions would result in the Common Shares trading at a price equal to or close to NAV.&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;Pursuant to the 1940 Act, the Fund may repurchase its Common Shares on a securities exchange (provided that the Fund has informed its shareholders within the preceding six months of its intention to repurchase such Common Shares) or as otherwise permitted in accordance with Rule&#160;23c-1 under the 1940 Act. Under Rule&#160;23c-1, certain conditions must be met for such alternative purchases regarding, among other things, distribution of net income for the preceding fiscal year, asset coverage with respect to the Fund&#x2019;s senior debt and equity securities, identity of the sellers, price paid, brokerage commissions, prior notice to shareholders of an intention to purchase shares and purchasing in a manner and on a basis which does not discriminate unfairly against the other shareholders through their interest in the Fund. In addition, Rule&#160;23c-1 requires the Fund to file notices of such purchase with the SEC. Additionally, pursuant to Rule&#160;23c-1(a)(10)&#160;under the 1940 Act, the Fund may also repurchase its outstanding Common Shares outside of the open market share repurchase program.&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;strong&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;PREFERRED SHARES&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The Fund does not currently have any preferred stock outstanding.&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The Fund&#x2019;s Agreement and Declaration of Trust provides that the Board may classify or reclassify any unissued Common Shares into one or more additional or other classes or series, with rights as determined by the Board, by action by the Board without the approval of the holders of Common Shares. Holders of Common Shares have no preemptive right to purchase any preferred shares that might be issued. The terms of any preferred shares, including its dividend rate, liquidation preference and redemption provisions, will be determined by the Board, subject to applicable law and the Fund&#x2019;s Agreement and Declaration of Trust. Thus, the Board could authorize the issuance of preferred shares with terms and conditions which could have the effect of delaying, deferring or preventing a transaction or a change in control that might involve a premium price for holders of the Fund&#x2019;s Common Shares or otherwise be in their best interest.&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              
                &lt;div style="font-size:10pt;font-family:Times New Roman"&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;If the Fund issues series of preferred shares, it will pay dividends to the holders of the preferred shares at a fixed rate, which may be reset after an initial period, as described in the prospectus supplement accompanying a preferred shares offering.&lt;/p&gt;
                &lt;/div&gt;
              
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;Upon a liquidation, holders of preferred shares will be entitled to receive out of the assets of the Fund available for distribution to shareholders (after payment of claims of the Fund&#x2019;s creditors but before any distributions with respect to the Fund&#x2019;s Common Shares or any other class of shares of the Fund ranking junior to the preferred shares as to liquidation payments) an amount per share equal to such share&#x2019;s liquidation preference plus any accumulated but unpaid distributions (whether or not earned or declared, excluding interest thereon) to the date of distribution, and such shareholders shall be entitled to no further participation in any distribution or payment in connection with such liquidation. The preferred shares carry one vote per share on all matters on which such shares are entitled to vote. The preferred shares will, upon issuance, be fully paid and&#160;non-assessable&#160;and will have no preemptive, exchange or conversion rights. The Fund will not issue any class of shares senior to the preferred shares.&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;i&gt;Asset Maintenance Requirements&lt;/i&gt;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The Fund must satisfy asset maintenance requirements under the 1940 Act with respect to its preferred shares. Under the 1940 Act, such debt or preferred shares may be issued only if immediately after such issuance the value of the Fund&#x2019;s total assets (less ordinary course liabilities) is at least 300% of the amount of any debt outstanding and at least 200% of the amount of any preferred shares and debt outstanding.&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The Fund will be required under the statement of preferences of the preferred shares to determine whether it has, as of the last business day of each March, June, September&#160;and December&#160;of each year, an &#x201c;asset coverage&#x201d; (as defined in the 1940 Act) of at least 200% (or such higher or lower percentage as may be required at the time under the 1940 Act) with respect to all outstanding senior securities of the Fund that are debt or shares, including any outstanding preferred shares. If the Fund fails to maintain the asset coverage required under the 1940 Act on such dates and such failure is not cured within 60 calendar days, the Fund may, and in certain circumstances will be required to, mandatorily redeem the number of preferred shares sufficient to satisfy such asset coverage.&lt;/p&gt;
            &lt;/div&gt;
          
              &lt;div&gt;&#160;&lt;/div&gt;
            
            &lt;div&gt;
              
                &lt;div&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;i&gt;Restrictions on Dividends and Other Distributions for the Preferred Shares&lt;/i&gt;&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;So long as any preferred shares are outstanding, the Fund may not pay any dividend or distribution (other than a dividend or distribution paid in Common Shares or in options, warrants or rights to subscribe for or purchase Common Shares) in respect of the Common Shares or call for redemption, redeem, purchase or otherwise acquire for consideration any Common Shares (except by conversion into or exchange for shares of the Fund ranking junior to the preferred shares as to the payment of dividends or distributions and the distribution of assets upon liquidation), unless:&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
                  &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse;border-spacing:0px"&gt;
                    
                      &lt;tr&gt;
                        &lt;td style="width:5%;text-align:justify"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;width:3%;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="vertical-align:top;width:1%;text-align:justify"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;the Fund has declared and paid (or provided to the relevant dividend paying agent) all cumulative distributions on the Fund&#x2019;s outstanding preferred shares due on or prior to the date of such Common Shares dividend or distribution;&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                    
                  &lt;/table&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
                  &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse;border-spacing:0px"&gt;
                    
                      &lt;tr&gt;
                        &lt;td style="width:5%;text-align:justify"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;width:3%;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="vertical-align:top;width:1%;text-align:justify"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;the Fund has redeemed the full number of preferred shares to be redeemed pursuant to any mandatory redemption provision in the Fund&#x2019;s Agreement and Declaration of Trust and&#160;By-Laws;&#160;and&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                    
                  &lt;/table&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
                  &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse;border-spacing:0px"&gt;
                    
                      &lt;tr&gt;
                        &lt;td style="width:5%;text-align:justify"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;width:3%;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="vertical-align:top;width:1%;text-align:justify"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;after making the distribution, the Fund meets applicable asset coverage requirements described &#x201c;Asset Maintenance Requirements.&#x201d;&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                    
                  &lt;/table&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;No full distribution will be declared or made on any series of preferred shares for any dividend period, or part thereof, unless full cumulative distributions due through the most recent dividend payment dates therefor for all outstanding series of preferred shares of the Fund ranking on a parity with such series as to distributions have been or contemporaneously are declared and made. If full cumulative distributions due have not been made on all outstanding preferred shares of the Fund ranking on a parity with such series of preferred shares as to the payment of distributions, any distributions being paid on the preferred shares will be paid as nearly pro rata as possible in proportion to the respective amounts of distributions accumulated but unmade on each such series of preferred shares on the relevant dividend payment date. The Fund&#x2019;s obligation to make distributions on the preferred shares will be subordinate to its obligations to pay interest and principal, when due, on any senior securities representing debt.&lt;/p&gt;
                &lt;/div&gt;
              
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              
                &lt;div&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;i&gt;Liquidation Preference&lt;/i&gt;&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Fund, the holders of preferred shares then outstanding will be entitled to receive a preferential liquidating distribution, which is expected to equal the original purchase price per preferred share plus accumulated and unpaid dividends, whether or not declared, before any distribution of assets is made to holders of Common Shares. After payment of the full amount of the liquidating distribution to which they are entitled, the holders of preferred shares will not be entitled to any further participation in any distribution of assets by the Fund.&lt;/p&gt;
                &lt;/div&gt;
              
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              
                &lt;div&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;i&gt;Voting Rights&lt;/i&gt;&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;Except as otherwise stated in this prospectus, specified in the Fund&#x2019;s Agreement and Declaration of Trust and&#160;By-Laws&#160;or resolved by the Board or as otherwise required by applicable law, holders of preferred shares shall be entitled to one vote per share held on each matter submitted to a vote of the shareholders of the Fund and will vote together with holders of Common Shares and of any other preferred shares then outstanding as a single class. In connection with the election of the Fund&#x2019;s Trustees, holders of the outstanding preferred shares, voting together as a single class, will be entitled at all times to elect two of the Fund&#x2019;s Trustees, and the remaining Trustees will be elected by holders of Common Shares and holders of preferred shares, voting together as a single class. In addition, if (i)&#160;at any time dividends and distributions on outstanding preferred shares are unpaid in an amount equal to at least two full years&#x2019; dividends and distributions thereon and sufficient cash or specified securities have not been deposited with the applicable paying agent for the payment of such accumulated dividends and distributions or (ii)&#160;at any time holders of any other series of preferred shares are entitled to elect a majority of the Trustees of the Fund under the 1940 Act or the applicable statement of preferences creating such shares, then the number of Trustees constituting the Board will be adjusted such that, when added to the two Trustees elected exclusively by the holders of preferred shares as described above, would then constitute a simple majority of the Board as so adjusted. Such additional Trustees will be elected by the holders of the outstanding preferred shares, voting together as a single class, at a special meeting of shareholders which will be called as soon as practicable and will be held not less than ten nor more than thirty days after the mailing date of the meeting notice. If the Fund fails to send such meeting notice or to call such a special meeting, the meeting may be called by any preferred shareholder on like notice. The terms of office of the persons who are Trustees at the time of that election will continue. If the Fund thereafter pays, or declares and sets apart for payment in full, all dividends and distributions payable on all outstanding preferred shares for all past dividend periods or the holders of other series of preferred shares are no longer entitled to elect such additional Trustees, the additional voting rights of the holders of the preferred shares as described above will cease, and the terms of office of all of the additional Trustees elected by the holders of the preferred shares (but not of the Trustees with respect to whose election the holders of Common Shares were entitled to vote or the two Trustees the holders of preferred shares have the right to elect as a separate class in any event) will terminate at the earliest time permitted by law.&lt;/p&gt;
                &lt;/div&gt;
              
              &lt;div style="display:none"&gt;
                
                  &lt;div&gt;&#160;&lt;/div&gt;
                
              &lt;/div&gt;
            &lt;/div&gt;
          
              &lt;div&gt;&#160;&lt;/div&gt;
            
            &lt;div&gt;
              
                &lt;div&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;So long as any preferred shares are outstanding, the Fund will not, without the affirmative vote of the holders of a majority (as defined in the 1940 Act) of the preferred shares outstanding at the time, and present and voting on such matter, voting separately as one class, amend, alter or repeal the provisions of the applicable statement of preferences, so as to in the aggregate adversely affect any of the rights and preferences set forth in any statement of preferences with respect to such preferred shares. Also, to the extent permitted under the 1940 Act, in the event shares of more than one series of preferred shares are outstanding, the Fund will not approve any of the actions set forth in the preceding sentence which in the aggregate adversely affect the rights and preferences expressly set forth in the applicable statement of preferences with respect to such shares of a series of preferred shares differently than those of a holder of shares of any other series of preferred shares without the affirmative vote of the holders of at least a majority of the preferred shares of each series adversely affected and outstanding at such time (each such adversely affected series voting separately as a class to the extent its rights are affected differently). Unless a higher percentage is required under the Agreement and Declaration of Trust and&#160;By-Laws&#160;or applicable provisions of the Delaware Statutory Trust Act or the 1940 Act, the affirmative vote of a majority of the votes entitled to be cast by holders of outstanding preferred shares, voting together as a single class, will be required to approve any plan of reorganization adversely affecting the preferred shares or any action requiring a vote of security holders under Section&#160;13(a)&#160;of the 1940 Act, including, among other things, changes in the Fund&#x2019;s&#160;sub-classification&#160;as&#160;a&#160;closed-end&#160;investment&#160;company to&#160;an&#160;open-end&#160;company&#160;or changes in its fundamental investment restrictions. As a result of these voting rights, the Fund&#x2019;s ability to take any such actions may be impeded to the extent that there are any preferred shares outstanding. The Board presently intends that, except as otherwise indicated in this prospectus and except as otherwise required by applicable law, holders of preferred shares will have equal voting rights with holders of Common Shares (one vote per share, unless otherwise required by the 1940 Act) and will vote together with holders of Common Shares as a single class. The phrase &#x201c;vote of the holders of a majority of the outstanding preferred shares&#x201d; (or any like phrase) means, in accordance with Section&#160;2(a)(42) of the 1940 Act, the vote, at the annual or a special meeting of the shareholders of the Fund duly called (i)&#160;of 67% or more of the preferred shares present at such meeting, if the holders of more than 50% of the outstanding preferred shares are present or represented by proxy, or (ii)&#160;more than 50% of the outstanding preferred shares, whichever is less. The class vote of holders of preferred shares described above in each case will be in addition to a separate vote of the requisite percentage of Common Shares, and any other preferred shares, voting together as a single class, that may be necessary to authorize the action in question. An increase in the number of authorized preferred shares pursuant to the Agreement and Declaration of Trust and&#160;By-Laws&#160;or the issuance of additional shares of any series of preferred shares pursuant to the Agreement and Declaration of Trust and&#160;By-Laws&#160;shall not in and of itself be considered to adversely affect the rights and preferences of the preferred shares.&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The foregoing voting provisions will not apply to any preferred shares if, at or prior to the time when the act with respect to which such vote otherwise would be required will be effected, such shares will have been redeemed or called for redemption and sufficient cash or cash equivalents provided to the applicable paying agent to effect such redemption. The holders of preferred shares will have no preemptive rights or rights to cumulative voting.&lt;/p&gt;
                &lt;/div&gt;
              
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              
                &lt;div&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;i&gt;Limitation on Issuance of Preferred Shares&lt;/i&gt;&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;So long as the Fund has preferred shares outstanding, and subject to compliance with the Fund&#x2019;s investment objective, policies and restrictions, the Fund may issue and sell shares of additional preferred shares provided that the Fund will, immediately after giving effect to the issuance of such additional preferred shares and to its receipt and application of the proceeds thereof (including, without limitation, to the redemption of preferred shares to be redeemed out of such proceeds), have an &#x201c;asset coverage&#x201d; for all senior securities of the Fund which are shares, as defined in the 1940 Act, of at least 200% of the sum of the liquidation preference of the preferred shares of the Fund then outstanding and all indebtedness of the Fund constituting senior securities and no such additional preferred shares will have any preference or priority over any other preferred shares of the Fund upon the distribution of the assets of the Fund or in respect of the payment of dividends or distributions.&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The Fund will consider from time to time whether to offer additional preferred shares or securities representing indebtedness and may issue such additional securities if the Board concludes that such an offering would be consistent with the Fund&#x2019;s Agreement and Declaration of Trust and&#160;By-Laws&#160;and applicable law, and in the best interest of existing common shareholders.&lt;/p&gt;
                &lt;/div&gt;
              
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;span style="text-transform:uppercase"&gt;&lt;strong&gt;Notes&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;The Fund does not currently have any notes outstanding.&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The Agreement and Declaration of Trust authorizes the issuance of debt securities or notes, with rights as determined by the Board, by action of the Board without the approval of the Common Shareholders.&#160;To the extent the Trustees authorize the issuance of any notes, the Trustees are also permitted to amend or supplement the Agreement and Declaration of Trust, as they deem appropriate. Any such amendment or supplement may set forth the rights, preferences, powers and privileges of such notes.&lt;/p&gt;
            &lt;/div&gt;
          
              &lt;div&gt;&#160;&lt;/div&gt;
            
            &lt;div&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;Under the 1940 Act, the Fund may only issue one class of senior securities representing indebtedness, which in the aggregate must have asset coverage immediately after the time of issuance of at least 300%. So long as&#160;notes&#160;are outstanding, additional debt securities must rank on a parity with&#160;notes&#160;with respect to the payment of interest and upon the distribution of the Fund&#x2019;s assets.&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;A Prospectus Supplement relating to any&#160;notes&#160;will include specific terms relating to the offering. The terms to be stated in a Prospectus Supplement will include the following:&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse;border-spacing:0px"&gt;
                
                  &lt;tr&gt;
                    &lt;td style="width:12%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:2%"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;the form and title of the security;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                
              &lt;/table&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse;border-spacing:0px"&gt;
                
                  &lt;tr&gt;
                    &lt;td style="width:12%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:2%"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;the aggregate principal amount of the securities;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                
              &lt;/table&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse;border-spacing:0px"&gt;
                
                  &lt;tr&gt;
                    &lt;td style="width:12%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:2%"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;the interest rate of the securities;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                
              &lt;/table&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse;border-spacing:0px"&gt;
                
                  &lt;tr&gt;
                    &lt;td style="width:12%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:2%"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;whether the interest rate for the securities will be determined by auction or remarketing;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                
              &lt;/table&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse;border-spacing:0px"&gt;
                
                  &lt;tr&gt;
                    &lt;td style="width:12%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:2%"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;the maturity dates on which the principal of the securities will be payable;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                
              &lt;/table&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse;border-spacing:0px"&gt;
                
                  &lt;tr&gt;
                    &lt;td style="width:12%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:2%"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;the frequency with which auctions or remarketings, if any, will be held;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                
              &lt;/table&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse;border-spacing:0px"&gt;
                
                  &lt;tr&gt;
                    &lt;td style="width:12%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:2%"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;any changes to or additional events of default or covenants;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                
              &lt;/table&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse;border-spacing:0px"&gt;
                
                  &lt;tr&gt;
                    &lt;td style="width:12%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:2%"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;any minimum period prior to which the securities may not be called;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                
              &lt;/table&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse;border-spacing:0px"&gt;
                
                  &lt;tr&gt;
                    &lt;td style="width:12%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:2%"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;any optional or mandatory call or redemption provisions;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                
              &lt;/table&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse;border-spacing:0px"&gt;
                
                  &lt;tr&gt;
                    &lt;td style="width:12%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:2%"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;the credit rating of the&#160;notes;&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                
              &lt;/table&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse;border-spacing:0px"&gt;
                
                  &lt;tr&gt;
                    &lt;td style="width:12%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:2%"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;if applicable, a discussion of the material U.S. federal income tax considerations applicable to the issuance of the&#160;notes; and&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                
              &lt;/table&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse;border-spacing:0px"&gt;
                
                  &lt;tr&gt;
                    &lt;td style="width:12%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:2%"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                    &lt;td style="vertical-align:top;width:1%"&gt;&#160;&lt;/td&gt;
                    &lt;td style="vertical-align:top"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;any other terms of the securities.&lt;/span&gt;&lt;/td&gt;
                  &lt;/tr&gt;
                
              &lt;/table&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The Prospectus Supplement will describe the interest payment provisions relating to&#160;notes. Interest on&#160;notes&#160;will be payable when due as described in the related Prospectus Supplement. If the Fund does not pay interest when due, it will trigger an event of default and the Fund will be restricted from declaring dividends and making other distributions with respect to its&#160;Common Shares&#160;and&#160;preferred shares.&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;Under the requirements of the 1940 Act, immediately after issuing any&#160;notes&#160;the value of the Fund&#x2019;s total assets, less certain ordinary course liabilities, must equal or exceed 300% of the amount of the&#160;notes&#160;outstanding. Other types of borrowings also may result in the Fund being subject to similar covenants in credit agreements.&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;Additionally, the 1940 Act requires that the Fund prohibit the declaration of any dividend or distribution (other than a dividend or distribution paid in the Fund&#x2019;s common or&#160;preferred shares&#160;or in options, warrants or rights to subscribe for or purchase the Fund&#x2019;s common or&#160;preferred shares) in respect of the Fund&#x2019;s common or&#160;preferred shares, or call for redemption, redeem, purchase or otherwise acquire for consideration any such fund common or&#160;preferred shares, unless the Fund&#x2019;s&#160;notes&#160;have asset coverage of at least 300% (200% in the case of a dividend or distribution on&#160;preferred shares) after deducting the amount of such dividend, distribution, or acquisition price, as the case may be. These 1940 Act requirements do not apply to any promissory note or other evidence of indebtedness issued in consideration of any loan, extension, or renewal thereof, made by a bank or other person and privately arranged, and not intended to be publicly distributed; however, any such borrowings may result in the Fund being subject to similar covenants in credit agreements. Moreover, the Indenture related to the&#160;notes&#160;could contain provisions more restrictive than those required by the 1940 Act, and any such provisions would be described in the related Prospectus Supplement.&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;Upon the occurrence and continuance of an event of default, the holders of a majority in principal amount of a series of outstanding&#160;notes&#160;or the trustee will be able to declare the principal amount of that series of&#160;notes&#160;immediately due and payable upon written notice to the Fund. A default that relates only to one series of&#160;notes&#160;does not affect any other series and the holders of such other series of&#160;notes&#160;will not be entitled to receive notice of such a default under the Indenture. Upon an event of default relating to bankruptcy, insolvency or other similar laws, acceleration of maturity will occur automatically with respect to all series. At any time after a declaration of acceleration with respect to a series of&#160;notes&#160;has been made, and before a judgment or decree for payment of the money due has been obtained, the holders of a majority in principal amount of the outstanding&#160;notes&#160;of that series, by written notice to the Fund and the trustee, may rescind and annul the declaration of acceleration and its consequences if all events of default with respect to that series of&#160;notes, other than the&#160;non-payment&#160;of the principal of that series of&#160;notes&#160;which has become due solely by such declaration of acceleration, have been cured or waived and other conditions have been met.&lt;/p&gt;
            &lt;/div&gt;
          
              &lt;div&gt;&#160;&lt;/div&gt;
            
            &lt;div&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;In the event of (a)&#160;any insolvency or bankruptcy case or proceeding, or any receivership, liquidation, reorganization or other similar case or proceeding in connection therewith, relative to the Fund or to the Fund&#x2019;s creditors, as such, or to the Fund&#x2019;s assets, or (b)&#160;any liquidation, dissolution or other winding up of the Fund, whether voluntary or involuntary and whether or not involving insolvency or bankruptcy, or (c)&#160;any assignment for the benefit of creditors or any other marshalling of assets and liabilities of the Fund, then (after any payments with respect to any secured creditor of the Fund outstanding at such time) and in any such event the holders of&#160;notes&#160;shall be entitled to receive payment in full of all amounts due or to become due on or in respect of all&#160;notes&#160;(including any interest accruing thereon after the commencement of any such case or proceeding), or provision shall be made for such payment in cash or cash equivalents or otherwise in a manner satisfactory to the holders of the&#160;notes, before the holders of any of the Fund&#x2019;s common or&#160;preferred shares&#160;are entitled to receive any payment on account of any redemption proceeds, liquidation preference or dividends from such shares. The holders of&#160;notes&#160;shall be entitled to receive, for application to the payment thereof, any payment or distribution of any kind or character, whether in cash, property or securities, including any such payment or distribution which may be payable or deliverable by reason of the payment of any other indebtedness of the Fund being subordinated to the payment of the&#160;notes, which may be payable or deliverable in respect of the&#160;notes&#160;in any such case, proceeding, dissolution, liquidation or other winding up event.&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;Unsecured creditors may include, without limitation, service providers including the Adviser, Custodian, administrator, auction agent, broker-dealers and the trustee, pursuant to the terms of various contracts with the Fund. Secured creditors may include without limitation parties entering into any interest rate swap, floor or cap transactions, or other similar transactions with the Fund that create liens, pledges, charges, security interests, security agreements or other encumbrances on the Fund&#x2019;s assets.&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;A consolidation, reorganization or merger of the Fund with or into any other company, or a sale, lease or exchange of all or substantially all of the Fund&#x2019;s assets in consideration for the issuance of equity securities of another company shall not be deemed to be a liquidation, dissolution or winding up of the Fund.&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The&#160;notes&#160;have no voting rights, except as mentioned below and to the extent required by law or as otherwise provided in the Indenture relating to the acceleration of maturity upon the occurrence and continuance of an event of default. In connection with the&#160;notes&#160;or certain other borrowings (if any), the 1940 Act does in certain circumstances grant to the note holders or lenders certain voting rights. The 1940 Act requires that provision is made either (i)&#160;that, if on the last business day of each of twelve consecutive calendar months such&#160;notes&#160;shall have an asset coverage of less than 100%, the holders of such&#160;notes&#160;voting as a class shall be entitled to elect at least a majority of the members of the Fund&#x2019;s Trustees, such voting right to continue until such&#160;notes&#160;shall have an asset coverage of 110% or more on the last business day of each of three consecutive calendar months, or (ii)&#160;that, if on the last business day of each of twenty-four consecutive calendar months such&#160;notes&#160;shall have an asset coverage of less than 100%, an event of default shall be deemed to have occurred. It is expected that, unless otherwise stated in the related Prospectus Supplement, provision will be made that, if on the last business day of each of twenty-four consecutive calendar months such&#160;notes&#160;shall have an asset coverage of less than 100%, an event of default shall be deemed to have occurred. These 1940 Act requirements do not apply to any promissory note or other evidence of indebtedness issued in consideration of any loan, extension, or renewal thereof, made by a bank or other person and privately arranged, and not intended to be publicly distributed; however, any such borrowings may result in the Fund being subject to similar covenants in credit agreements. As reflected above, the Indenture relating to the&#160;notes&#160;may also grant to the note holders voting rights relating to the acceleration of maturity upon the occurrence and continuance of an event of default, and any such rights would be described in the related Prospectus Supplement.&lt;/p&gt;
            &lt;/div&gt;
          
              &lt;div&gt;&#160;&lt;/div&gt;
            
            &lt;div&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;DESCRIPTION OF &lt;span style="font-size:10pt;font-family:Times New Roman"&gt;SUBSCRIPTION RIGHTS&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              
                &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The Fund may issue subscription rights to holders of Common Shares to purchase Common Shares. Subscription rights may be issued independently or together with any other offered security and may or may not be transferable by the person purchasing or receiving the subscription rights. In connection with a subscription rights offering to holders of Common Shares, the Fund would distribute certificates evidencing the subscription rights and a Prospectus Supplement to the Fund&#x2019;s common shareholders as of the record date that the Fund sets for determining the shareholders eligible to receive subscription rights in such subscription rights offering. For complete terms of the subscription rights, please refer to the actual terms of such subscription rights which will be set forth in the subscription rights agreement relating to such subscription rights and described in the Prospectus Supplement.&lt;/p&gt;
              
            &lt;/div&gt;
          
              &lt;div&gt;&#160;&lt;/div&gt;
            
                &lt;div&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The applicable Prospectus Supplement, which would accompany this Prospectus, would describe the following terms of subscription rights in respect of which this Prospectus is being delivered:&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
                  &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-spacing:0px"&gt;
                    
                      &lt;tr style="vertical-align:top"&gt;
                        &lt;td style="width:24px"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:24px;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;the period of time the offering would remain open (which will be open a minimum number of days such that all record holders would be eligible to participate in the offering and will not be open longer than 120 days);&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                    
                  &lt;/table&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
                  &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-spacing:0px"&gt;
                    
                      &lt;tr style="vertical-align:top"&gt;
                        &lt;td style="width:24px"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:24px;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;the title of such subscription rights;&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                    
                  &lt;/table&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
                  &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-spacing:0px"&gt;
                    
                      &lt;tr style="vertical-align:top"&gt;
                        &lt;td style="width:24px"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:24px;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;the exercise price for such subscription rights (or method of calculation thereof);&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                    
                  &lt;/table&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
                  &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-spacing:0px"&gt;
                    
                      &lt;tr style="vertical-align:top"&gt;
                        &lt;td style="width:24px"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:24px;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;the number of such subscription rights issued in respect of each share;&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                    
                  &lt;/table&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
                  &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-spacing:0px"&gt;
                    
                      &lt;tr style="vertical-align:top"&gt;
                        &lt;td style="width:24px"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:24px;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;the number of rights required to purchase a single share;&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                    
                  &lt;/table&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
                  &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-spacing:0px"&gt;
                    
                      &lt;tr style="vertical-align:top"&gt;
                        &lt;td style="width:24px"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:24px;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;the extent to which such subscription rights are transferable and the market on which they may be traded if they are transferable;&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                    
                  &lt;/table&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
                  &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-spacing:0px"&gt;
                    
                      &lt;tr style="vertical-align:top"&gt;
                        &lt;td style="width:24px"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:24px;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;if applicable, a discussion of certain U.S. federal income tax considerations applicable to the issuance or exercise of such subscription rights;&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                    
                  &lt;/table&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"&gt;&#160;&lt;/p&gt;
                  &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-spacing:0px"&gt;
                    
                      &lt;tr style="vertical-align:top"&gt;
                        &lt;td style="width:24px"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:24px;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;the date on which the right to exercise such subscription rights will commence, and the date on which such right will expire (subject to any extension);&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                    
                  &lt;/table&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
                  &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-spacing:0px"&gt;
                    
                      &lt;tr style="vertical-align:top"&gt;
                        &lt;td style="width:24px"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:24px;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;the extent to which such subscription rights include an over-subscription privilege with respect to unsubscribed securities and the terms of such over-subscription privilege;&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                    
                  &lt;/table&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
                  &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-spacing:0px"&gt;
                    
                      &lt;tr style="vertical-align:top"&gt;
                        &lt;td style="width:24px"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:24px;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;any termination right the Fund may have in connection with such subscription rights offering;&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                    
                  &lt;/table&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
                  &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-spacing:0px"&gt;
                    
                      &lt;tr style="vertical-align:top"&gt;
                        &lt;td style="width:24px"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:24px;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;the expected trading market, if any, for rights; and&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                    
                  &lt;/table&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
                  &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-spacing:0px"&gt;
                    
                      &lt;tr style="vertical-align:top"&gt;
                        &lt;td style="width:24px"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:24px;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;any other terms of such subscription rights, including exercise, settlement and other procedures and limitations relating to the transfer and exercise of such subscription rights.&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                    
                  &lt;/table&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;Exercise of Subscription Right&lt;/strong&gt;&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;Each subscription right would entitle the holder of the subscription right to purchase for cash such number of shares at such exercise price as in each case is set forth in, or be determinable as set forth in the Prospectus Supplement relating to the subscription rights offered thereby. Subscription rights would be exercisable at any time up to the close of business on the expiration date for such subscription rights set forth in the Prospectus Supplement. After the close of business on the expiration date, all unexercised subscription rights would become void.&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;Upon expiration of the rights offering and the receipt of payment and the subscription rights certificate properly completed and duly executed at the corporate trust office of the subscription rights agent or any other office indicated in the Prospectus Supplement, the Fund would issue, as soon as practicable, the shares purchased as a result of such exercise. To the extent permissible under applicable law, the Fund may determine to offer any unsubscribed offered securities directly to persons other than shareholders, to or through agents, underwriters or dealers or through a combination of such methods, as set forth in the applicable Prospectus Supplement.&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;Transferable Rights Offering&lt;/strong&gt;&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;Subscription rights issued by the Fund may be transferrable. The distribution to shareholders of transferable rights, which may themselves have intrinsic value, also will afford non-participating shareholders the potential of receiving cash payment upon the sale of the rights, receipt of which may be viewed as partial compensation for any dilution of their interests that may occur as a result of the rights offering. In a transferrable rights offering, management of the Fund will use its best efforts to ensure an adequate trading market in the rights for use by shareholders who do not exercise such rights. However, there can be no assurance that a market for transferable rights will develop or, if such a market does develop, what the price of the transferable rights will be. In a transferrable rights offering to purchase Common Shares at a price below NAV, the subscription ratio will not be less than 1-for-3, that is the holders of Common Shares of record on the record date of the rights offering will receive one right for each outstanding Common Share owned on the record date and the rights will entitle their holders to purchase one new Common Share for every three rights held (provided that any Common Shareholder who owns fewer than three Common Shares as of the record date may subscribe for one full Common Share). Assuming the exercise of all rights, such a rights offering would result in an approximately 33 1&#x2044;3% increase in the Fund&#x2019;s Common Shares outstanding.&lt;/p&gt;
                &lt;/div&gt;
              
                  &lt;div&gt;&#160;&lt;/div&gt;
                
            &lt;div&gt;
              
                &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;i&gt;Additional Information on the Transferability of Rights.&lt;/i&gt; &#160;The staff of the SEC has interpreted the 1940 Act as not requiring shareholder approval of a transferable rights offering to purchase Common Shares at a price below the then current NAV so long as certain conditions are met, including: (i)&#160;a good faith determination by a fund's board that such offering would result in a net benefit to existing shareholders; (ii)&#160;the offering fully protects shareholders' preemptive rights and does not discriminate among shareholders (except for the possible effect of not offering fractional Rights); (iii)&#160;management uses its best efforts to ensure an adequate trading market in the rights for use by shareholders who do not exercise such rights; and (iv)&#160;the ratio of a transferable rights offering does not exceed one new share for each three rights held.&lt;/p&gt;
              
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;REPURCHASE AGREEMENTS, REVERSE REPURCHASE AGREEMENTS AND DERIVATIVES&lt;/strong&gt;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The Fund may engage in repurchase agreements with broker-dealers, banks and other financial institutions to earn incremental income on temporarily available cash which would otherwise be uninvested. A repurchase agreement is a short-term investment in which the purchaser (i.e., the Fund) acquires ownership of a security and the seller agrees to repurchase the obligation at a future time and set price, thereby determining the yield during the holding period. Repurchase agreements involve certain risks in the event of default by the other party. The Fund may enter into repurchase agreements with broker-dealers, banks and other financial institutions deemed to be creditworthy.&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;Repurchase agreements are required to be fully collateralized by the underlying securities and are considered to be loans under the 1940 Act. The Fund pays for such securities only upon physical delivery or evidence of book entry transfer to the account of a custodian or bank acting as agent. The seller under a repurchase agreement will be required to maintain the value of the underlying collateral securities marked-to-market daily at not less than the repurchase price. The underlying securities (normally securities of the U.S. government and its agencies or instrumentalities) may have maturity dates exceeding one (1)&#160;year.&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The Fund may borrow through entering into reverse repurchase agreements under which the Fund sells portfolio investments to financial institutions such as banks and broker-dealers and generally agrees to repurchase them at a mutually agreed future date and price. Generally, the effect of a reverse repurchase agreement is that, during the term of the agreement, the Fund can obtain and reinvest all or most of the cash value of the portfolio investment it sold under the agreement and still be entitled to the returns associated with such portfolio investment&#x2014;thereby resulting in a transaction similar to a borrowing and giving rise to leverage for the Fund. The Fund may utilize reverse repurchase agreements when it is anticipated that the interest income to be earned from the investment of the proceeds of the transaction is greater than the interest expense of the transaction.&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;In the event the buyer of securities under a reverse repurchase agreement files for bankruptcy or becomes insolvent, the Fund's use of the proceeds of the agreement may be restricted pending a determination by the other party, or its trustee or receiver, whether to enforce the Fund's obligation to repurchase the securities.&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The Fund also expects to enter into other transactions that may give rise to a form of leverage including, among others, swaps, futures and forward contracts, options and other derivative transactions. However, these transactions may represent a form of economic leverage and will create risks. Further, the Fund may incur losses on such transactions (including the entire amount of the Fund&#x2019;s investment in such transaction) even if they are covered.&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;Investing in derivatives can involve leverage risk, liquidity risk, counterparty risk, market risk and operational/legal risk. The Fund may utilize options, forward contracts, futures contracts and options on futures contracts. These instruments involve risks, including the imperfect correlation between the value of such instruments and the underlying assets, the possible default by the counterparty to the transaction (i.e., counterparty risk), illiquidity of the derivative instrument and, to the extent the prediction as to certain market movements is incorrect, the risk that the use of such instruments could result in losses greater than if they had not been used. In addition, transactions in such instruments may involve commissions and other costs, which may increase the Fund&#x2019;s expenses and reduce its return. Amounts paid as premiums and cash or other assets held in margin accounts with respect to such instruments are not otherwise available to the Fund for investment purposes.&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;Further, the use of such instruments by the Fund could create the possibility that losses on the instrument would be greater than gains in the value of the Fund&#x2019;s position. In addition, futures and options markets could be illiquid in some circumstances, and certain over-the-counter options could have no markets. As a result, in certain markets, the Fund might not be able to close out a position without incurring substantial losses. Such transactions should tend to minimize the risk of loss due to a decline in the value of the hedged position and, at the same time, limit any potential gain to the Fund that might result from an increase in value of the position. In addition, the daily variation margin requirements for futures contracts create a greater ongoing potential financial risk than would purchases of call options, in which case the market exposure is limited to the cost of the initial premium and transaction costs. Losses resulting from the use of hedging will reduce the NAV of the Fund&#x2019;s securities, and possibly income, and the losses can be greater than if hedging had not been used. Forward contracts may limit gains on portfolio securities that could otherwise be realized had they not been utilized and could result in losses. The contracts may also increase the Fund&#x2019;s volatility and may involve a significant amount of risk relative to the investment of cash. The use of put and call options may result in losses to the Fund, force the sale of portfolio securities at inopportune times or for prices other than at current market values, limit the amount of appreciation the Fund can realize on its investments or cause the Fund to hold a security it might otherwise sell. The Fund will be subject to credit risk with respect to the counterparties to any transactions in options, forward contracts, futures contracts or options on futures contracts. If a counterparty becomes bankrupt or otherwise fails to perform its obligations under a derivative contract due to financial difficulties, the Fund may experience significant delays in obtaining any recovery under the derivative contract in bankruptcy or other reorganization proceeding. The Fund may obtain only a limited recovery or may obtain no recovery in such circumstances.&lt;/p&gt;
            &lt;/div&gt;
          
              &lt;div&gt;&#160;&lt;/div&gt;
            
            &lt;div&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;When conducted outside the United States, transactions in options, forward contracts, futures contracts or options on futures contracts may not be regulated as rigorously as in the United States, may not involve a clearing mechanism and related guarantees, and are subject to the risk of governmental actions affecting trading in, or the prices of, foreign securities, currencies and other instruments. The value of such positions also could be adversely affected by: (i)&#160;other complex foreign political, legal and economic factors; (ii)&#160;lesser availability than in the United States of data on which to make trading decisions; (iii)&#160;delays in the Fund&#x2019;s ability to act upon economic events occurring in foreign markets during non-business hours in the United States; (iv)&#160;the imposition of different exercise and settlement terms and procedures and margin requirements than in the United States; and (v)&#160;lower trading volume and liquidity.&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;Rule&#160;18f-4 under the 1940 Act governs a registered investment company&#x2019;s use of derivatives, short sales, reverse repurchase agreements, and certain other instruments. Under Rule&#160;18f-4, a fund&#x2019;s derivatives exposure is limited through a value-at-risk test and requires the adoption and implementation of a derivatives risk management program for certain derivatives users. However, subject to certain conditions, funds that do not invest heavily in derivatives may be deemed limited derivatives users and would not be subject to the full requirements of Rule&#160;18f-4. Under the rule, when a fund trades reverse repurchase agreements or similar financing transactions, including certain tender option bonds, it needs to aggregate the amount of indebtedness associated with the reverse repurchase agreements or similar financing transactions with the aggregate amount of any other senior securities representing indebtedness when calculating the fund&#x2019;s asset coverage ratio or treat all such transactions as derivatives transactions. In addition, under the rule, the fund is permitted to invest in a security on a when-issued or forward-settling basis, or with a non-standard settlement cycle, and the transaction will be deemed not to involve a senior security (as defined under Section&#160;18(g)&#160;of the 1940 Act), provided that, (i)&#160;the fund intends to physically settle the transaction and (ii)&#160;the transaction will settle within 35 days of its trade date (the &#x201c;Delayed-Settlement Securities Provision&#x201d;). A fund may otherwise engage in when-issued, forward-settling and non-standard settlement cycle securities transactions that do not meet the conditions of the Delayed-Settlement Securities Provision so long as a fund treats any such transaction as a &#x201c;derivatives transaction&#x201d; for purposes of compliance with the rule. Furthermore, under the rule, a fund is permitted to enter into an unfunded commitment agreement, and such unfunded commitment agreement will not be subject to the asset coverage requirements under the 1940 Act, if a fund reasonably believes, at the time it enters into such agreement, that it will have sufficient cash and cash equivalents to meet its obligations with respect to all such agreements as they come due. These requirements may limit the ability of a fund to use derivatives, and reverse repurchase agreements and similar financing transactions as part of its investment strategies. These requirements may increase the cost of a fund&#x2019;s investments and cost of doing business, which could adversely affect investors. The Fund&#x2019;s implementation of Rule&#160;18-4 is limited by its fundamental investment restrictions.&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;CREDIT FACILITY AND NOTES&lt;/strong&gt;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The Fund utilizes leverage through borrowings and may enter into definitive agreements with respect to a credit facility or other borrowing program. The Fund may negotiate with commercial banks to arrange a credit facility pursuant to which the Fund would expect to be entitled to borrow an amount equal to approximately one-third (1/3) of the Fund&#x2019;s total assets (inclusive of the amount borrowed). Any such borrowings would constitute financial leverage. Such a credit facility is not expected to be convertible into any other securities of the Fund, outstanding amounts are expected to be pre-payable by the Fund prior to final maturity without significant penalty and there are not expected to be any sinking fund or mandatory retirement provisions. Outstanding amounts would be payable at maturity or such earlier times as required by the agreement. The Fund may be required to prepay outstanding amounts under the credit facility or incur a penalty rate of interest upon the occurrence of certain events of default. The Fund would be expected to indemnify the lenders under the credit facility against liabilities they may incur in connection with the credit facility. The Fund is currently a party to the Credit Facility. Although the Fund currently intends to renew the Credit Facility, prior to its expiration date there can be no assurance that the Fund will be able to do so or do so on terms similar to the current Credit Facility, which may adversely affect the ability of the Fund to pursue its investment objectives and strategies.&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The Fund may also obtain leverage through the issuance of notes representing indebtedness. Such notes are not expected to be convertible into any other securities of the Fund. Outstanding amounts would be payable at maturity or such earlier times as required by the terms of the notes. The Fund may be required to prepay outstanding amounts under the notes or incur a penalty rate of interest upon the occurrence of certain events of default.&lt;/p&gt;
            &lt;/div&gt;
          
              &lt;div&gt;&#160;&lt;/div&gt;
            
            &lt;div&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The Fund may use leverage to the maximum extent permitted by the 1940 Act. Under the 1940 Act, the Fund is not permitted to incur indebtedness, including through the issuance of notes or other debt securities, unless immediately thereafter the total asset value of the Fund&#x2019;s portfolio is at least 300% of the aggregate amount of the outstanding indebtedness (&lt;i&gt;i.e.&lt;/i&gt;, such aggregate amount may not exceed 33&#160;1/3&#160;% of the Fund&#x2019;s total assets). In addition, the Fund is not permitted to declare any cash distribution on its Common Shares unless, at the time of such declaration, the NAV of the Fund&#x2019;s portfolio (determined after deducting the amount of such distribution) is at least 300% of such aggregate amount. If the Fund issues notes, borrows money or enters into a credit facility, the Fund intends, to the extent possible, to retire outstanding debt, from time to time, to maintain coverage of any outstanding indebtedness of at least 300%.&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The Fund may seek the highest credit rating possible from one or more NRSROs on any notes that the Fund issues. In such a case, the Fund intends that, as long as notes are outstanding, the composition of its portfolio will reflect guidelines established by such NRSRO. Although, as of the date hereof, no NRSRO has established guidelines relating to the Fund&#x2019;s notes, based on previous guidelines established by NRSROs for the securities of other issuers, the Fund anticipates that the guidelines with respect to the notes will establish a set of tests for portfolio composition and asset coverage that supplement (and in some cases are more restrictive than) the applicable requirements under the 1940 Act. Although, at this time, no assurance can be given as to the nature or extent of the guidelines which may be imposed in connection with obtaining a rating of the notes, the Fund currently anticipates that such guidelines will include asset coverage requirements which are more restrictive than those under the 1940 Act, restrictions on certain portfolio investments and investment practices, requirements that the Fund maintain a portion of its assets in short-term, high-quality investments and certain mandatory redemption requirements relating to the notes. No assurance can be given that the guidelines actually imposed with respect to the notes by a NRSRO will be more or less restrictive than as described in this prospectus.&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
              &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;In addition, the Fund expects that any notes or a credit facility would contain covenants that, among other things, will likely impose geographic exposure limitations, credit quality minimums, liquidity minimums, concentration limitations and currency hedging requirements on the Fund. These covenants would also likely limit the Fund&#x2019;s ability to pay distributions in certain circumstances, incur additional debt, change its fundamental investment policies, engage in certain transactions, including mergers and consolidations, and may require asset coverage ratios in addition to those required by the 1940 Act. The Fund would only agree to a limit on its ability to change its fundamental investment policies if doing so was consistent with the 1940 Act and applicable state law. The Fund may be required to pledge (or otherwise grant a security interest in) some or all of its assets and to maintain a portion of its assets in cash or high-grade securities as a reserve against interest or principal payments and expenses. The Fund expects that any notes or credit facility would have customary covenant, negative covenant and default provisions. There can be no assurance that the Fund will enter into an agreement for a credit facility, or issue notes, on terms and conditions representative of the foregoing, or that additional material terms will not apply. In addition, if entered into or issued, any such notes or credit facility may in the future be replaced or refinanced by one or more credit facilities having substantially different terms or by the issuance of preferred shares and/or notes or debt securities. The Fund is currently a party to the Credit Facility. See &#x201c;Investment Objectives and Policies &#x2014; Use of Leverage and Related Risks&#x201d; for more information.&lt;/p&gt;
            &lt;/div&gt;
          
              &lt;div&gt;&#160;&lt;/div&gt;
            
      &lt;div&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;ANTI-TAKEOVER AND CERTAIN OTHER PROVISIONS IN THE AGREEMENT AND DECLARATION OF TRUST&lt;/strong&gt;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;Anti-Takeover Provisions&lt;/strong&gt;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The Agreement and Declaration of Trust includes provisions that could have the effect of limiting the ability of other entities or persons to acquire control of the Fund or to change the composition of the Board. These provisions may have the effect of discouraging attempts to acquire control of the Fund. The Board is divided into three classes, with the term of one class expiring at each annual meeting of the Fund&#x2019;s shareholders. At each annual meeting, one class of Trustees is elected to a three-year term. This provision could delay the replacement of a majority of the Board. A Trustee may be removed from office without cause only by a written instrument signed or adopted by two-thirds of the remaining Trustees or by a vote of the holders of at least two-thirds of the class of shares of the Fund that are entitled to elect a Trustee and that are entitled to vote on the matter.&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The Agreement and Declaration of Trust provides that the Fund may not merge with another entity, or sell, lease or exchange all or substantially all of its assets without the approval of at least two-thirds of the Trustees and 75% of the affected shareholders.&lt;/p&gt;
      &lt;/div&gt;
    
        &lt;div&gt;&#160;&lt;/div&gt;
      
      &lt;div&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;In addition, the Agreement and Declaration of Trust requires the favorable vote of the holders of at least 80% of the outstanding shares of each class of the Fund, voting as a class, then entitled to vote to approve, adopt or authorize certain transactions with 5%-or-greater holders of the Fund&#x2019;s outstanding shares and their affiliates or associates, unless two-thirds of the Board have approved by resolution a memorandum of understanding with such holders, in which case normal voting requirements would be in effect. For purposes of these provisions, a 5%-or-greater holder of outstanding shares (a &#x201c;Principal Shareholder&#x201d;) refers to any person who, whether directly or indirectly and whether alone or together with its affiliates and associates, beneficially owns 5% or more of the outstanding shares of beneficial interest of the Fund. The transactions subject to these special approval requirements are: (i)&#160;the merger or consolidation of the Fund or any subsidiary of the Fund with or into any Principal Shareholder; (ii)&#160;the issuance of any securities of the Fund to any Principal Shareholder for cash (other than pursuant to any automatic dividend reinvestment plan or pursuant to any offering in which such Principal Shareholder acquires securities that represent no greater a percentage of any class or series of securities being offered than the percentage of any class of shares beneficially owned by such Principal Shareholder immediately prior to such offering or, in the case of securities, offered in respect of another class or series, the percentage of such other class or series beneficially owned by such Principal Shareholder immediately prior to such offering); (iii)&#160;the sale, lease or exchange of all or any substantial part of the assets of the Fund to any Principal Shareholder (except assets having an aggregate fair market value of less than $1,000,000, aggregating for the purpose of such computation all assets sold, leased or exchanged in any series of similar transactions within a twelve-month period); (iv)&#160;the sale, lease or exchange to the Fund or any subsidiary thereof, in exchange for securities of the Fund, of any assets of any Principal Shareholder (except assets having an aggregate fair market value of less than $1,000,000, aggregating for the purposes of such computation all assets sold, leased or exchanged in any series of similar transactions within a twelve-month period); or (v)&#160;the purchase by the Fund, or any entity controlled by the Fund, of any Common Shares from any Principal Shareholder or any person to whom any Principal Shareholder transferred Common Shares.&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;Reference should be made to the Agreement and Declaration of Trust on file with the SEC for the full text of these provisions.&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The Agreement and Declaration of Trust provides that the Fund shall indemnify the Trustees and officers of the Fund (each such person being an &#x201c;indemnitee&#x201d;) against any liabilities and expenses, including amounts paid in satisfaction of judgments, in compromise or as fines and penalties, and reasonable counsel fees reasonably incurred by such indemnitee in connection with the defense or disposition of any action, suit or other proceeding, whether civil or criminal, before any court or administrative or investigative body in which he may be or may have been involved as a party or otherwise (other than, except as authorized by the Trustees, as the plaintiff or complainant) or with which he may be or may have been threatened, while acting in any capacity set forth in Section&#160;4.2 of the Agreement and Declaration of Trust by reason of his having acted in any such capacity, except with respect to any matter as to which he shall not have acted in good faith in the reasonable belief that his action was in the best interest of the Trust or, in the ease of any criminal proceeding, as to which he shall have had reasonable cause to believe that the conduct was unlawful, provided, however, that no indemnitee shall be indemnified against any liability to any person or any expense of such indemnitee arising by reason of (i)&#160;willful misfeasance, (ii)&#160;bad faith, (iii)&#160;gross negligence (negligence in the ease of affiliated indemnitees), or (iv)&#160;reckless disregard of the duties involved in the conduct of his position (the conduct referred to in such clauses (i)&#160;through (iv)&#160;being sometimes referred to herein as &#x201c;disabling conduct&#x201d;). The Fund shall make advance payments in connection with the expenses of defending any action with respect to which indemnification might be sought if the Fund receives a written affirmation by the indemnitee of the indemnitee&#x2019;s good faith belief that the standards of conduct necessary for indemnification have been met and a written undertaking to reimburse the Fund unless it is subsequently determined that he is entitled to such indemnification and if a majority of the Trustees determine that the applicable standards of conduct necessary for indemnification appear to have been met. In addition, at least one of the following conditions must be met: (1)&#160;the indemnitee shall provide adequate security for his undertaking, (2)&#160;the Fund shall be insured against losses arising by reason of any lawful advances, or (3)&#160;a majority of a quorum of those Trustees who are neither interested persons of the Fund nor parties to the proceeding, or if a majority vote of such quorum so direct, independent legal counsel in a written opinion, shall conclude, based on a review of readily available facts (as opposed to a full trial-type inquiry), that there is substantial reason to believe that the indemnitee ultimately will be found entitled to indemnification.&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;Control Share Statute&lt;/strong&gt;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The Fund is subject to the control share acquisition statute (the &#x201c;Control Share Statute&#x201d;) contained in Subchapter III of the Delaware Statutory Trust Act (the &#x201c;DSTA&#x201d;), which became automatically applicable to listed closed-end funds, such as the Fund, and the Fund has not broadly exempted acquisition of control shares in its governing instrument.&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The Control Share Statute provides for thresholds at which a person has the power to directly or indirectly exercise or direct the exercise of the voting power of shares in the election of trustees, above which shares are considered control shares. Whether a voting power threshold is met is determined by aggregating the holdings of the acquirer as well as those of any &#x201c;associate,&#x201d; as discussed below. These thresholds are:&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
        &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt;border-spacing:0px" width="100%"&gt;
          
            &lt;tr style="vertical-align:top"&gt;
              &lt;td style="width:0.25in"&gt;&lt;/td&gt;
              &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Times New Roman, Times, Serif"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif"&gt;10% or more, but less than 15% of all voting power;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
          
        &lt;/table&gt;
        &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt;border-spacing:0px" width="100%"&gt;
          
            &lt;tr style="vertical-align:top"&gt;
              &lt;td style="width:0.25in"&gt;&lt;/td&gt;
              &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Times New Roman, Times, Serif"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif"&gt;15% or more, but less than 20% of all voting power;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
          
        &lt;/table&gt;
        &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt;border-spacing:0px" width="100%"&gt;
          
            &lt;tr style="vertical-align:top"&gt;
              &lt;td style="width:0.25in"&gt;&lt;/td&gt;
              &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Times New Roman, Times, Serif"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif"&gt;20% or more, but less than 25% of all voting power;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
          
        &lt;/table&gt;
        &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt;border-spacing:0px" width="100%"&gt;
          
            &lt;tr style="vertical-align:top"&gt;
              &lt;td style="width:0.25in"&gt;&lt;/td&gt;
              &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Times New Roman, Times, Serif"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif"&gt;25% or more, but less than 30% of all voting power;&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
          
        &lt;/table&gt;
        &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt;border-spacing:0px" width="100%"&gt;
          
            &lt;tr style="vertical-align:top"&gt;
              &lt;td style="width:0.25in"&gt;&lt;/td&gt;
              &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Times New Roman, Times, Serif"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif"&gt;30% or more, but less than a majority of all voting power; or&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
          
        &lt;/table&gt;
        &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;margin-top:0pt;margin-bottom:0pt;border-spacing:0px" width="100%"&gt;
          
            &lt;tr style="vertical-align:top"&gt;
              &lt;td style="width:0.25in"&gt;&lt;/td&gt;
              &lt;td style="width:0.25in"&gt;&lt;span style="font-family:Times New Roman, Times, Serif"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
              &lt;td style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif"&gt;a majority or more of all voting power.&lt;/span&gt;&lt;/td&gt;
            &lt;/tr&gt;
          
        &lt;/table&gt;
      &lt;/div&gt;
    
        &lt;div&gt;&#160;&lt;/div&gt;
      
      &lt;div&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;Once a shareholder reaches a threshold, such shareholder has no voting rights under the DSTA with respect to shares acquired in excess of that threshold (i.e., the &#x201c;control shares&#x201d;) unless approved by a vote of the non-acquiring shareholders, or otherwise exempted by the fund&#x2019;s board of trustees. Approval by non-acquiring shareholders requires the affirmative vote of two-thirds of all votes entitled to be cast on the matter, excluding shares held by the acquiring shareholder and its associates as well as shares held by certain insiders of a Fund. Alternatively, the Board is permitted, but not obligated, to exempt acquisitions specifically, generally, or generally by type of control shares, either in advance or retroactively. As of the date hereof, the Board has not received notice of the occurrence of a control share acquisition nor has been requested to exempt any acquisition. Therefore, the Board has not determined whether the application of the Control Share Statute to an acquisition of Fund shares is in the best interest of the Fund and its shareholders and has not exempted any acquisition of control shares nor made any determination with respect to the provisions of the Control Share Statute.&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The Control Share Statute may protect the long-term interests of fund shareholders by limiting the ability of certain investors to use their ownership to attempt to disrupt a fund&#x2019;s long-term strategy such as by forcing a liquidity event. The Control Share Statute may limit the ability of certain shareholders to use their ownership to cause a change with respect to the Fund.&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The foregoing is only a summary of certain aspects of the Control Share Statute. Some uncertainty around the application under the 1940 Act of state control share statutes exists as a result of recent federal and state court decisions that have found that certain control share acquisition provisions violate the 1940 Act.&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;CONVERSION TO OPEN-END FUND&lt;/strong&gt;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
        &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The Fund may be converted to an open-end management investment company at any time if approved by a majority of the Trustees then in office, by the holders of not less than 75% of the Trust&#x2019;s outstanding Shares entitled to vote thereon and by such vote or votes of the holders of any class or classes or series of Shares as may be required by the 1940 Act. The composition of the Fund&#x2019;s portfolio and/or its investment policies could prohibit the Fund from complying with regulations of the SEC applicable to open-end management investment companies unless significant changes in portfolio holdings, which might be difficult and could involve losses, and investment policies are made. Conversion of the Fund to an open-end management investment company also would require the redemption of any outstanding preferred shares and could require the repayment of borrowings, which would reduce the leveraged capital structure of the Fund with respect to the Common Shares. In the event of conversion, the Common Shares would cease to be listed on the NYSE or other national securities exchange or market system. The Board believes the closed-end structure is desirable, given the Fund&#x2019;s investment objectives and policies. Common shareholders of an open-end management investment company can require the company to redeem their shares at any time (except in certain circumstances as authorized by or under the 1940 Act) at their NAV, less such redemption charge, if any, as might be in effect at the time of a redemption. If converted to an open-end fund, the Fund expects to pay all redemption requests in cash, but reserves the right to pay redemption requests in a combination of cash or securities. If such partial payment in securities were made, investors may incur brokerage costs in converting such securities to cash. If the Fund were converted to an open-end fund, it is likely that new Common Shares would be sold at NAV plus a sales load.&lt;/p&gt;
      &lt;/div&gt;
    </cef:CapitalStockTableTextBlock>
    <cef:OutstandingSecuritiesTableTextBlock
      contextRef="C_20260803to20260803"
      id="Fxbrl_20260807124953037">
                &lt;table cellpadding="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif;border-spacing:0px"&gt;
                  
                    &lt;tr style="vertical-align:bottom"&gt;
                      &lt;td style="font:bold 10pt Times New Roman, Times, Serif;border-bottom:Black 1pt solid"&gt;Title&#160;of&#160;Class&lt;/td&gt;
                      &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;Amount&lt;br/&gt;Authorized&lt;/td&gt;
                      &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;Amount&#160;Held&#160;by&lt;br/&gt;the&#160;Fund&#160;or&#160;for&#160;its&lt;br/&gt;Account&lt;/td&gt;
                      &lt;td style="padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:bold 10pt Times New Roman, Times, Serif;text-align:center;border-bottom:Black 1pt solid"&gt;Amount&#160;Outstanding&lt;br/&gt;Exclusive&#160;of&#160;Common&lt;br/&gt;Shares&#160;Held&#160;by&#160;the&#160;Fund&lt;br/&gt;or&#160;for&#160;its&#160;Own&#160;Account&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                      &lt;td style="width:58%;font:10pt Times New Roman, Times, Serif;text-align:center"&gt;&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Common Shares&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="width:2%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:12%;font:10pt Times New Roman, Times, Serif;text-align:center"&gt;Unlimited&lt;/td&gt;
                      &lt;td style="width:2%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:10%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;0&lt;/td&gt;
                      &lt;td style="width:1%;font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:2%;font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="width:12%;font:10pt Times New Roman, Times, Serif;text-align:right"&gt;105,466,347&lt;/td&gt;
                    &lt;/tr&gt;
                  
                &lt;/table&gt;
              </cef:OutstandingSecuritiesTableTextBlock>
    <cef:OutstandingSecurityTitleTextBlock
      contextRef="C_20260803to20260803_usgaapStatementClassOfStockAxis_ck0001379400CommonSharesMember"
      id="Fxbrl_20260807124807163">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Common Shares&lt;/span&gt;</cef:OutstandingSecurityTitleTextBlock>
    <cef:OutstandingSecurityHeldShares
      contextRef="C_20260803to20260803_usgaapStatementClassOfStockAxis_ck0001379400CommonSharesMember"
      decimals="INF"
      id="Fxbrl_20260807124853023"
      unitRef="SHARES">0</cef:OutstandingSecurityHeldShares>
    <cef:OutstandingSecurityNotHeldShares
      contextRef="C_20260803to20260803_usgaapStatementClassOfStockAxis_ck0001379400CommonSharesMember"
      decimals="INF"
      id="Fxbrl_20260807124907804"
      unitRef="SHARES">105466347</cef:OutstandingSecurityNotHeldShares>
    <cef:SecurityTitleTextBlock
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807125041716">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;COMMON SHARES&lt;/span&gt;</cef:SecurityTitleTextBlock>
    <cef:DistributionsMayReducePrincipalTextBlock
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807135322452">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;The 1940 Act or the terms of any borrowings may limit the payment of dividends to the holders of Common Shares.&lt;/span&gt;</cef:DistributionsMayReducePrincipalTextBlock>
    <cef:SecurityVotingRightsTextBlock
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807135348702">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Each whole share shall be entitled to one vote as to matters on which it is entitled to vote pursuant to the terms of the Agreement and Declaration of Trust on file with the SEC.&lt;/span&gt;</cef:SecurityVotingRightsTextBlock>
    <cef:SecurityLiquidationRightsTextBlock
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807135420679">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;Upon liquidation of the Fund, after paying or adequately providing for the payment of all liabilities of the Fund, and upon receipt of such releases, indemnities and refunding agreements as they deem necessary for their protection, the Trustees may distribute the remaining managed assets of the Fund among its shareholders.&lt;/span&gt;</cef:SecurityLiquidationRightsTextBlock>
    <cef:SecurityPreemptiveAndOtherRightsTextBlock
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807135543513">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;There are no pre-emptive rights associated with the shares.&lt;/span&gt;</cef:SecurityPreemptiveAndOtherRightsTextBlock>
    <cef:SecurityLiabilitiesTextBlock
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807135518968">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;The Agreement and Declaration of Trust provides that the Fund&#x2019;s shareholders are not liable for any liabilities of the Fund.&lt;/span&gt;</cef:SecurityLiabilitiesTextBlock>
    <cef:SharePriceTableTextBlock
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807140356294">
              &lt;div&gt;
                &lt;table cellpadding="0" style="border-collapse:collapse;width:100%;font:10pt Times New Roman, Times, Serif;border-spacing:0px"&gt;
                  
                    &lt;tr style="vertical-align:bottom"&gt;
                      &lt;td style="font-size:10pt;text-align:center"&gt;&#160;&lt;/td&gt;
                      &lt;td style="text-align:center;font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="6" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;strong&gt;NYSE Market Price&lt;sup&gt;(1)&lt;/sup&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:center;padding-bottom:1pt;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="text-align:center;font:bold 10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="6" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;strong&gt;NAV at NYSE Market Price&lt;sup&gt;(1)&lt;/sup&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="text-align:center;padding-bottom:1pt;font-size:10pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="text-align:center;font-size:10pt;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="6" style="border-bottom:Black 1pt solid;font-size:10pt;text-align:center"&gt;&lt;strong&gt;Market Premium/(Discount) to NAV on Date of NYSE Market Price&lt;sup&gt;(1)&lt;/sup&gt;&lt;/strong&gt;&lt;/td&gt;
                      &lt;td style="text-align:center;padding-bottom:1pt;font-size:10pt"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="vertical-align:bottom"&gt;
                      &lt;td style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;strong&gt;Quarter Ended&lt;sup&gt;(2)&lt;/sup&gt;&lt;/strong&gt;&lt;/span&gt;&lt;/td&gt;
                      &lt;td style="padding-bottom:1pt;text-align:center;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;High&lt;/td&gt;
                      &lt;td style="padding-bottom:1pt;text-align:center;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="padding-bottom:1pt;text-align:center;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;Low&lt;/td&gt;
                      &lt;td style="padding-bottom:1pt;text-align:center;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="padding-bottom:1pt;text-align:center;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;High&lt;/td&gt;
                      &lt;td style="padding-bottom:1pt;text-align:center;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="padding-bottom:1pt;text-align:center;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;Low&lt;/td&gt;
                      &lt;td style="padding-bottom:1pt;text-align:center;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="padding-bottom:1pt;text-align:center;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;High&lt;/td&gt;
                      &lt;td style="padding-bottom:1pt;text-align:center;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="padding-bottom:1pt;text-align:center;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td colspan="2" style="border-bottom:Black 1pt solid;font:bold 10pt Times New Roman, Times, Serif;text-align:center"&gt;Low&lt;/td&gt;
                      &lt;td style="padding-bottom:1pt;text-align:center;font:bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                      &lt;td style="width:16%;font:10pt Times New Roman, Times, Serif;text-align:center;padding-bottom:1pt"&gt;July&#160;31, 2026&lt;/td&gt;
                      &lt;td style="width:2%;font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:10%;text-align:right"&gt;10.63&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:2%;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:10%;text-align:right"&gt;10.06&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:2%;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:10%;text-align:right"&gt;10.90&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:2%;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:10%;text-align:right"&gt;10.43&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:2%;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:10%;text-align:right"&gt;(2.48&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;padding-bottom:1pt;text-align:left"&gt;)%&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:2%;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:10%;text-align:right"&gt;(3.55&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;width:1%;padding-bottom:1pt;text-align:left"&gt;)%&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="vertical-align:bottom;background-color:White"&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:center;padding-bottom:1pt"&gt;April&#160;30, 2026&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10.70&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;8.81&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10.63&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;9.60&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(0.66&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;)%&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(8.23&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;)%&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:center;padding-bottom:1pt"&gt;January&#160;31, 2026&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10.13&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;9.20&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10.42&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;9.92&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(2.78&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;)%&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(7.26&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;)%&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="vertical-align:bottom;background-color:White"&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:center"&gt;October&#160;31, 2025&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;9.74&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;8.80&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10.14&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;9.44&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(3.94&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(6.78&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;)%&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:center;padding-bottom:1pt"&gt;July&#160;31, 2025&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;9.12&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;8.29&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;9.89&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;9.17&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(7.79&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;)%&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(9.60&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;)%&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="vertical-align:bottom;background-color:White"&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:center;padding-bottom:1pt"&gt;April&#160;30, 2025&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;8.86&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;7.42&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;9.76&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;8.36&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(9.22&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;)%&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(11.24&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;)%&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:center;padding-bottom:1pt"&gt;January&#160;31, 2025&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;8.89&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;8.36&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;9.79&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;9.42&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(9.19&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;)%&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(11.25&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;)%&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="vertical-align:bottom;background-color:White"&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:center;padding-bottom:1pt"&gt;October&#160;31, 2024&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;9.10&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;8.03&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10.10&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;9.38&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(9.90&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;)%&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(14.39&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;)%&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:center;padding-bottom:1pt"&gt;July&#160;31, 2024&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;8.72&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;8.00&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;10.09&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;9.32&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(13.58&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;)%&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(14.16&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;)%&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="vertical-align:bottom;background-color:White"&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:center;padding-bottom:1pt"&gt;April&#160;30, 2024&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;8.29&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;7.78&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;9.69&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;9.27&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(14.45&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;)%&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(16.07&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;)%&lt;/td&gt;
                    &lt;/tr&gt;
                    &lt;tr style="vertical-align:bottom;background-color:rgb(204,238,255)"&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:center;padding-bottom:1pt"&gt;January&#160;31, 2024&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;8.12&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;7.31&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;9.62&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;8.61&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(15.59&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;)%&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:left"&gt;&#160;&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;text-align:right"&gt;(15.10&lt;/td&gt;
                      &lt;td style="font:10pt Times New Roman, Times, Serif;padding-bottom:1pt;text-align:left"&gt;)%&lt;/td&gt;
                    &lt;/tr&gt;
                  
                &lt;/table&gt;
                &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
                &lt;div style="width:25%"&gt;
                  &lt;div style="font-size:1pt;border-top:Black 1pt solid"&gt;&#160;&lt;/div&gt;
                &lt;/div&gt;
                &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 0.25in;text-indent:-0.25in"&gt;(1)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Source: Bloomberg L.P.&lt;/p&gt;
                &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0 0pt 0.25in;text-indent:-0.25in"&gt;(2)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Data presented are with respect to a short period of time and are not indicative of future performance.&lt;/p&gt;
              &lt;/div&gt;
            </cef:SharePriceTableTextBlock>
    <cef:HighestPriceOrBid
      contextRef="C_20260501to20260731"
      decimals="2"
      id="Fxbrl_20260807140451982"
      unitRef="Usd_per_Share">10.63</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20260501to20260731"
      decimals="2"
      id="Fxbrl_20260807140508176"
      unitRef="Usd_per_Share">10.06</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="C_20260501to20260731"
      decimals="2"
      id="Fxbrl_20260807140614668"
      unitRef="Usd_per_Share">10.9</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="C_20260501to20260731"
      decimals="2"
      id="Fxbrl_20260807140629332"
      unitRef="Usd_per_Share">10.43</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20260501to20260731"
      decimals="4"
      id="Fxbrl_20260807140802003"
      unitRef="Pure">-0.0248</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20260501to20260731"
      decimals="4"
      id="Fxbrl_20260807140842296"
      unitRef="Pure">-0.0355</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20260201to20260430"
      decimals="2"
      id="Fxbrl_20260807141309538_xbrl_20260807140451982"
      unitRef="Usd_per_Share">10.7</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20260201to20260430"
      decimals="2"
      id="Fxbrl_20260807141309538_xbrl_20260807140508176"
      unitRef="Usd_per_Share">8.81</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="C_20260201to20260430"
      decimals="2"
      id="Fxbrl_20260807141309538_xbrl_20260807140614668"
      unitRef="Usd_per_Share">10.63</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="C_20260201to20260430"
      decimals="2"
      id="Fxbrl_20260807141309538_xbrl_20260807140629332"
      unitRef="Usd_per_Share">9.6</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20260201to20260430"
      decimals="4"
      id="Fxbrl_20260807141309538_xbrl_20260807140802003"
      unitRef="Pure">-0.0066</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20260201to20260430"
      decimals="4"
      id="Fxbrl_20260807141309538_xbrl_20260807140842296"
      unitRef="Pure">-0.0823</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20251101to20260131"
      decimals="2"
      id="Fxbrl_20260807141325994_xbrl_20260807140451982"
      unitRef="Usd_per_Share">10.13</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20251101to20260131"
      decimals="2"
      id="Fxbrl_20260807141325994_xbrl_20260807140508176"
      unitRef="Usd_per_Share">9.2</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="C_20251101to20260131"
      decimals="2"
      id="Fxbrl_20260807141325994_xbrl_20260807140614668"
      unitRef="Usd_per_Share">10.42</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="C_20251101to20260131"
      decimals="2"
      id="Fxbrl_20260807141325994_xbrl_20260807140629332"
      unitRef="Usd_per_Share">9.92</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20251101to20260131"
      decimals="4"
      id="Fxbrl_20260807141325994_xbrl_20260807140802003"
      unitRef="Pure">-0.0278</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20251101to20260131"
      decimals="4"
      id="Fxbrl_20260807141325994_xbrl_20260807140842296"
      unitRef="Pure">-0.0726</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20250801to20251031"
      decimals="2"
      id="Fxbrl_20260807141327779_xbrl_20260807140451982"
      unitRef="Usd_per_Share">9.74</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20250801to20251031"
      decimals="2"
      id="Fxbrl_20260807141327779_xbrl_20260807140508176"
      unitRef="Usd_per_Share">8.8</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="C_20250801to20251031"
      decimals="2"
      id="Fxbrl_20260807141327779_xbrl_20260807140614668"
      unitRef="Usd_per_Share">10.14</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="C_20250801to20251031"
      decimals="2"
      id="Fxbrl_20260807141327779_xbrl_20260807140629332"
      unitRef="Usd_per_Share">9.44</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20250801to20251031"
      decimals="4"
      id="Fxbrl_20260807141327779_xbrl_20260807140802003"
      unitRef="Pure">-0.0394</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20250801to20251031"
      decimals="4"
      id="Fxbrl_20260807141327779_xbrl_20260807140842296"
      unitRef="Pure">-0.0678</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20250501to20250731"
      decimals="2"
      id="Fxbrl_20260807141329494_xbrl_20260807140451982"
      unitRef="Usd_per_Share">9.12</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20250501to20250731"
      decimals="2"
      id="Fxbrl_20260807141329494_xbrl_20260807140508176"
      unitRef="Usd_per_Share">8.29</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="C_20250501to20250731"
      decimals="2"
      id="Fxbrl_20260807141329494_xbrl_20260807140614668"
      unitRef="Usd_per_Share">9.89</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="C_20250501to20250731"
      decimals="2"
      id="Fxbrl_20260807141329494_xbrl_20260807140629332"
      unitRef="Usd_per_Share">9.17</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20250501to20250731"
      decimals="4"
      id="Fxbrl_20260807141329494_xbrl_20260807140802003"
      unitRef="Pure">-0.0779</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20250501to20250731"
      decimals="4"
      id="Fxbrl_20260807141329494_xbrl_20260807140842296"
      unitRef="Pure">-0.096</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20250201to20250430"
      decimals="2"
      id="Fxbrl_20260807141331229_xbrl_20260807140451982"
      unitRef="Usd_per_Share">8.86</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20250201to20250430"
      decimals="2"
      id="Fxbrl_20260807141331229_xbrl_20260807140508176"
      unitRef="Usd_per_Share">7.42</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="C_20250201to20250430"
      decimals="2"
      id="Fxbrl_20260807141331229_xbrl_20260807140614668"
      unitRef="Usd_per_Share">9.76</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="C_20250201to20250430"
      decimals="2"
      id="Fxbrl_20260807141331229_xbrl_20260807140629332"
      unitRef="Usd_per_Share">8.36</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20250201to20250430"
      decimals="4"
      id="Fxbrl_20260807141331229_xbrl_20260807140802003"
      unitRef="Pure">-0.0922</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20250201to20250430"
      decimals="4"
      id="Fxbrl_20260807141331229_xbrl_20260807140842296"
      unitRef="Pure">-0.1124</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20241101to20250131"
      decimals="2"
      id="Fxbrl_20260807141338373_xbrl_20260807140451982"
      unitRef="Usd_per_Share">8.89</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20241101to20250131"
      decimals="2"
      id="Fxbrl_20260807141338373_xbrl_20260807140508176"
      unitRef="Usd_per_Share">8.36</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="C_20241101to20250131"
      decimals="2"
      id="Fxbrl_20260807141338373_xbrl_20260807140614668"
      unitRef="Usd_per_Share">9.79</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="C_20241101to20250131"
      decimals="2"
      id="Fxbrl_20260807141338373_xbrl_20260807140629332"
      unitRef="Usd_per_Share">9.42</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20241101to20250131"
      decimals="4"
      id="Fxbrl_20260807141338373_xbrl_20260807140802003"
      unitRef="Pure">-0.0919</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20241101to20250131"
      decimals="4"
      id="Fxbrl_20260807141338373_xbrl_20260807140842296"
      unitRef="Pure">-0.1125</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20240801to20241031"
      decimals="2"
      id="Fxbrl_20260807141341787_xbrl_20260807140451982"
      unitRef="Usd_per_Share">9.1</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20240801to20241031"
      decimals="2"
      id="Fxbrl_20260807141341787_xbrl_20260807140508176"
      unitRef="Usd_per_Share">8.03</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="C_20240801to20241031"
      decimals="2"
      id="Fxbrl_20260807141341787_xbrl_20260807140614668"
      unitRef="Usd_per_Share">10.1</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="C_20240801to20241031"
      decimals="2"
      id="Fxbrl_20260807141341787_xbrl_20260807140629332"
      unitRef="Usd_per_Share">9.38</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20240801to20241031"
      decimals="4"
      id="Fxbrl_20260807141341787_xbrl_20260807140802003"
      unitRef="Pure">-0.099</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20240801to20241031"
      decimals="4"
      id="Fxbrl_20260807141341787_xbrl_20260807140842296"
      unitRef="Pure">-0.1439</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20240501to20240731"
      decimals="2"
      id="Fxbrl_20260807141343587_xbrl_20260807140451982"
      unitRef="Usd_per_Share">8.72</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20240501to20240731"
      decimals="2"
      id="Fxbrl_20260807141343587_xbrl_20260807140508176"
      unitRef="Usd_per_Share">8</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="C_20240501to20240731"
      decimals="2"
      id="Fxbrl_20260807141343587_xbrl_20260807140614668"
      unitRef="Usd_per_Share">10.09</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="C_20240501to20240731"
      decimals="2"
      id="Fxbrl_20260807141343587_xbrl_20260807140629332"
      unitRef="Usd_per_Share">9.32</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20240501to20240731"
      decimals="4"
      id="Fxbrl_20260807141343587_xbrl_20260807140802003"
      unitRef="Pure">-0.1358</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20240501to20240731"
      decimals="4"
      id="Fxbrl_20260807141343587_xbrl_20260807140842296"
      unitRef="Pure">-0.1416</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20240201to20240430"
      decimals="2"
      id="Fxbrl_20260807141345509_xbrl_20260807140451982"
      unitRef="Usd_per_Share">8.29</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20240201to20240430"
      decimals="2"
      id="Fxbrl_20260807141345509_xbrl_20260807140508176"
      unitRef="Usd_per_Share">7.78</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="C_20240201to20240430"
      decimals="2"
      id="Fxbrl_20260807141345509_xbrl_20260807140614668"
      unitRef="Usd_per_Share">9.69</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="C_20240201to20240430"
      decimals="2"
      id="Fxbrl_20260807141345509_xbrl_20260807140629332"
      unitRef="Usd_per_Share">9.27</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20240201to20240430"
      decimals="4"
      id="Fxbrl_20260807141345509_xbrl_20260807140802003"
      unitRef="Pure">-0.1445</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20240201to20240430"
      decimals="4"
      id="Fxbrl_20260807141345509_xbrl_20260807140842296"
      unitRef="Pure">-0.1607</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <cef:HighestPriceOrBid
      contextRef="C_20231101to20240131"
      decimals="2"
      id="Fxbrl_20260807141348066_xbrl_20260807140451982"
      unitRef="Usd_per_Share">8.12</cef:HighestPriceOrBid>
    <cef:LowestPriceOrBid
      contextRef="C_20231101to20240131"
      decimals="2"
      id="Fxbrl_20260807141348066_xbrl_20260807140508176"
      unitRef="Usd_per_Share">7.31</cef:LowestPriceOrBid>
    <cef:HighestPriceOrBidNav
      contextRef="C_20231101to20240131"
      decimals="2"
      id="Fxbrl_20260807141348066_xbrl_20260807140614668"
      unitRef="Usd_per_Share">9.62</cef:HighestPriceOrBidNav>
    <cef:LowestPriceOrBidNav
      contextRef="C_20231101to20240131"
      decimals="2"
      id="Fxbrl_20260807141348066_xbrl_20260807140629332"
      unitRef="Usd_per_Share">8.61</cef:LowestPriceOrBidNav>
    <cef:HighestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20231101to20240131"
      decimals="4"
      id="Fxbrl_20260807141348066_xbrl_20260807140802003"
      unitRef="Pure">-0.1559</cef:HighestPriceOrBidPremiumDiscountToNavPercent>
    <cef:LowestPriceOrBidPremiumDiscountToNavPercent
      contextRef="C_20231101to20240131"
      decimals="4"
      id="Fxbrl_20260807141348066_xbrl_20260807140842296"
      unitRef="Pure">-0.151</cef:LowestPriceOrBidPremiumDiscountToNavPercent>
    <us-gaap:NetAssetValuePerShare
      contextRef="C_20260803"
      decimals="2"
      id="Fxbrl_20260807170028725"
      unitRef="Usd_per_Share">10.57</us-gaap:NetAssetValuePerShare>
    <us-gaap:SharePrice
      contextRef="C_20260803"
      decimals="2"
      id="Fxbrl_20260807170101349"
      unitRef="Usd_per_Share">10.5</us-gaap:SharePrice>
    <cef:LatestPremiumDiscountToNavPercent
      contextRef="C_20260803to20260803"
      decimals="4"
      id="Fxbrl_20260807170226670"
      unitRef="Pure">-0.0066</cef:LatestPremiumDiscountToNavPercent>
    <cef:OutstandingSecuritiesTableTextBlock
      contextRef="C_20260807to20260807_usgaapStatementClassOfStockAxis_ck0001379400PreferredSharesMember"
      id="Fxbrl_20260807141228502">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;PREFERRED SHARES&lt;/span&gt;</cef:OutstandingSecuritiesTableTextBlock>
    <cef:SecurityDividendsTextBlock
      contextRef="C_20260807to20260807_usgaapStatementClassOfStockAxis_ck0001379400PreferredSharesMember"
      id="Fxbrl_20260807141311149">
                &lt;div style="font-size:10pt;font-family:Times New Roman"&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;If the Fund issues series of preferred shares, it will pay dividends to the holders of the preferred shares at a fixed rate, which may be reset after an initial period, as described in the prospectus supplement accompanying a preferred shares offering.&lt;/p&gt;
                &lt;/div&gt;
              </cef:SecurityDividendsTextBlock>
    <cef:PreferredStockRestrictionsArrearageTextBlock
      contextRef="C_20260807to20260807_usgaapStatementClassOfStockAxis_ck0001379400PreferredSharesMember"
      id="Fxbrl_20260807170500933">
                &lt;div&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;i&gt;Restrictions on Dividends and Other Distributions for the Preferred Shares&lt;/i&gt;&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;So long as any preferred shares are outstanding, the Fund may not pay any dividend or distribution (other than a dividend or distribution paid in Common Shares or in options, warrants or rights to subscribe for or purchase Common Shares) in respect of the Common Shares or call for redemption, redeem, purchase or otherwise acquire for consideration any Common Shares (except by conversion into or exchange for shares of the Fund ranking junior to the preferred shares as to the payment of dividends or distributions and the distribution of assets upon liquidation), unless:&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
                  &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse;border-spacing:0px"&gt;
                    
                      &lt;tr&gt;
                        &lt;td style="width:5%;text-align:justify"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;width:3%;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="vertical-align:top;width:1%;text-align:justify"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;the Fund has declared and paid (or provided to the relevant dividend paying agent) all cumulative distributions on the Fund&#x2019;s outstanding preferred shares due on or prior to the date of such Common Shares dividend or distribution;&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                    
                  &lt;/table&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
                  &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse;border-spacing:0px"&gt;
                    
                      &lt;tr&gt;
                        &lt;td style="width:5%;text-align:justify"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;width:3%;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="vertical-align:top;width:1%;text-align:justify"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;the Fund has redeemed the full number of preferred shares to be redeemed pursuant to any mandatory redemption provision in the Fund&#x2019;s Agreement and Declaration of Trust and&#160;By-Laws;&#160;and&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                    
                  &lt;/table&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
                  &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-collapse:collapse;border-spacing:0px"&gt;
                    
                      &lt;tr&gt;
                        &lt;td style="width:5%;text-align:justify"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;width:3%;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="vertical-align:top;width:1%;text-align:justify"&gt;&#160;&lt;/td&gt;
                        &lt;td style="vertical-align:top;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;after making the distribution, the Fund meets applicable asset coverage requirements described &#x201c;Asset Maintenance Requirements.&#x201d;&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                    
                  &lt;/table&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;No full distribution will be declared or made on any series of preferred shares for any dividend period, or part thereof, unless full cumulative distributions due through the most recent dividend payment dates therefor for all outstanding series of preferred shares of the Fund ranking on a parity with such series as to distributions have been or contemporaneously are declared and made. If full cumulative distributions due have not been made on all outstanding preferred shares of the Fund ranking on a parity with such series of preferred shares as to the payment of distributions, any distributions being paid on the preferred shares will be paid as nearly pro rata as possible in proportion to the respective amounts of distributions accumulated but unmade on each such series of preferred shares on the relevant dividend payment date. The Fund&#x2019;s obligation to make distributions on the preferred shares will be subordinate to its obligations to pay interest and principal, when due, on any senior securities representing debt.&lt;/p&gt;
                &lt;/div&gt;
              </cef:PreferredStockRestrictionsArrearageTextBlock>
    <cef:SecurityLiquidationRightsTextBlock
      contextRef="C_20260807to20260807_usgaapStatementClassOfStockAxis_ck0001379400PreferredSharesMember"
      id="Fxbrl_20260807165640190">
                &lt;div&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;i&gt;Liquidation Preference&lt;/i&gt;&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Fund, the holders of preferred shares then outstanding will be entitled to receive a preferential liquidating distribution, which is expected to equal the original purchase price per preferred share plus accumulated and unpaid dividends, whether or not declared, before any distribution of assets is made to holders of Common Shares. After payment of the full amount of the liquidating distribution to which they are entitled, the holders of preferred shares will not be entitled to any further participation in any distribution of assets by the Fund.&lt;/p&gt;
                &lt;/div&gt;
              </cef:SecurityLiquidationRightsTextBlock>
    <cef:SecurityVotingRightsTextBlock
      contextRef="C_20260807to20260807_usgaapStatementClassOfStockAxis_ck0001379400PreferredSharesMember"
      id="Fxbrl_20260807141519678">
                &lt;div&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;i&gt;Voting Rights&lt;/i&gt;&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;Except as otherwise stated in this prospectus, specified in the Fund&#x2019;s Agreement and Declaration of Trust and&#160;By-Laws&#160;or resolved by the Board or as otherwise required by applicable law, holders of preferred shares shall be entitled to one vote per share held on each matter submitted to a vote of the shareholders of the Fund and will vote together with holders of Common Shares and of any other preferred shares then outstanding as a single class. In connection with the election of the Fund&#x2019;s Trustees, holders of the outstanding preferred shares, voting together as a single class, will be entitled at all times to elect two of the Fund&#x2019;s Trustees, and the remaining Trustees will be elected by holders of Common Shares and holders of preferred shares, voting together as a single class. In addition, if (i)&#160;at any time dividends and distributions on outstanding preferred shares are unpaid in an amount equal to at least two full years&#x2019; dividends and distributions thereon and sufficient cash or specified securities have not been deposited with the applicable paying agent for the payment of such accumulated dividends and distributions or (ii)&#160;at any time holders of any other series of preferred shares are entitled to elect a majority of the Trustees of the Fund under the 1940 Act or the applicable statement of preferences creating such shares, then the number of Trustees constituting the Board will be adjusted such that, when added to the two Trustees elected exclusively by the holders of preferred shares as described above, would then constitute a simple majority of the Board as so adjusted. Such additional Trustees will be elected by the holders of the outstanding preferred shares, voting together as a single class, at a special meeting of shareholders which will be called as soon as practicable and will be held not less than ten nor more than thirty days after the mailing date of the meeting notice. If the Fund fails to send such meeting notice or to call such a special meeting, the meeting may be called by any preferred shareholder on like notice. The terms of office of the persons who are Trustees at the time of that election will continue. If the Fund thereafter pays, or declares and sets apart for payment in full, all dividends and distributions payable on all outstanding preferred shares for all past dividend periods or the holders of other series of preferred shares are no longer entitled to elect such additional Trustees, the additional voting rights of the holders of the preferred shares as described above will cease, and the terms of office of all of the additional Trustees elected by the holders of the preferred shares (but not of the Trustees with respect to whose election the holders of Common Shares were entitled to vote or the two Trustees the holders of preferred shares have the right to elect as a separate class in any event) will terminate at the earliest time permitted by law.&lt;/p&gt;
                &lt;/div&gt;
              
                  &lt;div&gt;&#160;&lt;/div&gt;
                
                &lt;div&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;So long as any preferred shares are outstanding, the Fund will not, without the affirmative vote of the holders of a majority (as defined in the 1940 Act) of the preferred shares outstanding at the time, and present and voting on such matter, voting separately as one class, amend, alter or repeal the provisions of the applicable statement of preferences, so as to in the aggregate adversely affect any of the rights and preferences set forth in any statement of preferences with respect to such preferred shares. Also, to the extent permitted under the 1940 Act, in the event shares of more than one series of preferred shares are outstanding, the Fund will not approve any of the actions set forth in the preceding sentence which in the aggregate adversely affect the rights and preferences expressly set forth in the applicable statement of preferences with respect to such shares of a series of preferred shares differently than those of a holder of shares of any other series of preferred shares without the affirmative vote of the holders of at least a majority of the preferred shares of each series adversely affected and outstanding at such time (each such adversely affected series voting separately as a class to the extent its rights are affected differently). Unless a higher percentage is required under the Agreement and Declaration of Trust and&#160;By-Laws&#160;or applicable provisions of the Delaware Statutory Trust Act or the 1940 Act, the affirmative vote of a majority of the votes entitled to be cast by holders of outstanding preferred shares, voting together as a single class, will be required to approve any plan of reorganization adversely affecting the preferred shares or any action requiring a vote of security holders under Section&#160;13(a)&#160;of the 1940 Act, including, among other things, changes in the Fund&#x2019;s&#160;sub-classification&#160;as&#160;a&#160;closed-end&#160;investment&#160;company to&#160;an&#160;open-end&#160;company&#160;or changes in its fundamental investment restrictions. As a result of these voting rights, the Fund&#x2019;s ability to take any such actions may be impeded to the extent that there are any preferred shares outstanding. The Board presently intends that, except as otherwise indicated in this prospectus and except as otherwise required by applicable law, holders of preferred shares will have equal voting rights with holders of Common Shares (one vote per share, unless otherwise required by the 1940 Act) and will vote together with holders of Common Shares as a single class. The phrase &#x201c;vote of the holders of a majority of the outstanding preferred shares&#x201d; (or any like phrase) means, in accordance with Section&#160;2(a)(42) of the 1940 Act, the vote, at the annual or a special meeting of the shareholders of the Fund duly called (i)&#160;of 67% or more of the preferred shares present at such meeting, if the holders of more than 50% of the outstanding preferred shares are present or represented by proxy, or (ii)&#160;more than 50% of the outstanding preferred shares, whichever is less. The class vote of holders of preferred shares described above in each case will be in addition to a separate vote of the requisite percentage of Common Shares, and any other preferred shares, voting together as a single class, that may be necessary to authorize the action in question. An increase in the number of authorized preferred shares pursuant to the Agreement and Declaration of Trust and&#160;By-Laws&#160;or the issuance of additional shares of any series of preferred shares pursuant to the Agreement and Declaration of Trust and&#160;By-Laws&#160;shall not in and of itself be considered to adversely affect the rights and preferences of the preferred shares.&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The foregoing voting provisions will not apply to any preferred shares if, at or prior to the time when the act with respect to which such vote otherwise would be required will be effected, such shares will have been redeemed or called for redemption and sufficient cash or cash equivalents provided to the applicable paying agent to effect such redemption. The holders of preferred shares will have no preemptive rights or rights to cumulative voting.&lt;/p&gt;
                &lt;/div&gt;
              </cef:SecurityVotingRightsTextBlock>
    <cef:PreferredStockRestrictionsOtherTextBlock
      contextRef="C_20260807to20260807_usgaapStatementClassOfStockAxis_ck0001379400PreferredSharesMember"
      id="Fxbrl_20260807170534320">
                &lt;div&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;i&gt;Limitation on Issuance of Preferred Shares&lt;/i&gt;&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;So long as the Fund has preferred shares outstanding, and subject to compliance with the Fund&#x2019;s investment objective, policies and restrictions, the Fund may issue and sell shares of additional preferred shares provided that the Fund will, immediately after giving effect to the issuance of such additional preferred shares and to its receipt and application of the proceeds thereof (including, without limitation, to the redemption of preferred shares to be redeemed out of such proceeds), have an &#x201c;asset coverage&#x201d; for all senior securities of the Fund which are shares, as defined in the 1940 Act, of at least 200% of the sum of the liquidation preference of the preferred shares of the Fund then outstanding and all indebtedness of the Fund constituting senior securities and no such additional preferred shares will have any preference or priority over any other preferred shares of the Fund upon the distribution of the assets of the Fund or in respect of the payment of dividends or distributions.&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The Fund will consider from time to time whether to offer additional preferred shares or securities representing indebtedness and may issue such additional securities if the Board concludes that such an offering would be consistent with the Fund&#x2019;s Agreement and Declaration of Trust and&#160;By-Laws&#160;and applicable law, and in the best interest of existing common shareholders.&lt;/p&gt;
                &lt;/div&gt;
              </cef:PreferredStockRestrictionsOtherTextBlock>
    <cef:OtherSecurityTitleTextBlock
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807132752109">&lt;span style="font-size:10pt;font-family:Times New Roman"&gt;SUBSCRIPTION RIGHTS&lt;/span&gt;</cef:OtherSecurityTitleTextBlock>
    <cef:OtherSecurityDescriptionTextBlock
      contextRef="C_20260807to20260807"
      id="Fxbrl_20260807141714582">
                &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The Fund may issue subscription rights to holders of Common Shares to purchase Common Shares. Subscription rights may be issued independently or together with any other offered security and may or may not be transferable by the person purchasing or receiving the subscription rights. In connection with a subscription rights offering to holders of Common Shares, the Fund would distribute certificates evidencing the subscription rights and a Prospectus Supplement to the Fund&#x2019;s common shareholders as of the record date that the Fund sets for determining the shareholders eligible to receive subscription rights in such subscription rights offering. For complete terms of the subscription rights, please refer to the actual terms of such subscription rights which will be set forth in the subscription rights agreement relating to such subscription rights and described in the Prospectus Supplement.&lt;/p&gt;
              
            &lt;div&gt;
              
                &lt;div&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;The applicable Prospectus Supplement, which would accompany this Prospectus, would describe the following terms of subscription rights in respect of which this Prospectus is being delivered:&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
                  &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-spacing:0px"&gt;
                    
                      &lt;tr style="vertical-align:top"&gt;
                        &lt;td style="width:24px"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:24px;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;the period of time the offering would remain open (which will be open a minimum number of days such that all record holders would be eligible to participate in the offering and will not be open longer than 120 days);&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                    
                  &lt;/table&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
                  &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-spacing:0px"&gt;
                    
                      &lt;tr style="vertical-align:top"&gt;
                        &lt;td style="width:24px"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:24px;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;the title of such subscription rights;&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                    
                  &lt;/table&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
                  &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-spacing:0px"&gt;
                    
                      &lt;tr style="vertical-align:top"&gt;
                        &lt;td style="width:24px"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:24px;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;the exercise price for such subscription rights (or method of calculation thereof);&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                    
                  &lt;/table&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
                  &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-spacing:0px"&gt;
                    
                      &lt;tr style="vertical-align:top"&gt;
                        &lt;td style="width:24px"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:24px;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;the number of such subscription rights issued in respect of each share;&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                    
                  &lt;/table&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
                  &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-spacing:0px"&gt;
                    
                      &lt;tr style="vertical-align:top"&gt;
                        &lt;td style="width:24px"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:24px;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;the number of rights required to purchase a single share;&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                    
                  &lt;/table&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
                  &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-spacing:0px"&gt;
                    
                      &lt;tr style="vertical-align:top"&gt;
                        &lt;td style="width:24px"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:24px;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;the extent to which such subscription rights are transferable and the market on which they may be traded if they are transferable;&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                    
                  &lt;/table&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
                  &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-spacing:0px"&gt;
                    
                      &lt;tr style="vertical-align:top"&gt;
                        &lt;td style="width:24px"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:24px;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;if applicable, a discussion of certain U.S. federal income tax considerations applicable to the issuance or exercise of such subscription rights;&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                    
                  &lt;/table&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:center"&gt;&#160;&lt;/p&gt;
                  &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-spacing:0px"&gt;
                    
                      &lt;tr style="vertical-align:top"&gt;
                        &lt;td style="width:24px"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:24px;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;the date on which the right to exercise such subscription rights will commence, and the date on which such right will expire (subject to any extension);&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                    
                  &lt;/table&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
                  &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-spacing:0px"&gt;
                    
                      &lt;tr style="vertical-align:top"&gt;
                        &lt;td style="width:24px"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:24px;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;the extent to which such subscription rights include an over-subscription privilege with respect to unsubscribed securities and the terms of such over-subscription privilege;&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                    
                  &lt;/table&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
                  &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-spacing:0px"&gt;
                    
                      &lt;tr style="vertical-align:top"&gt;
                        &lt;td style="width:24px"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:24px;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;any termination right the Fund may have in connection with such subscription rights offering;&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                    
                  &lt;/table&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
                  &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-spacing:0px"&gt;
                    
                      &lt;tr style="vertical-align:top"&gt;
                        &lt;td style="width:24px"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:24px;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;the expected trading market, if any, for rights; and&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                    
                  &lt;/table&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&#160;&lt;/p&gt;
                  &lt;table cellpadding="0" style="font:10pt Times New Roman, Times, Serif;width:100%;border-spacing:0px"&gt;
                    
                      &lt;tr style="vertical-align:top"&gt;
                        &lt;td style="width:24px"&gt;&#160;&lt;/td&gt;
                        &lt;td style="width:24px;text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;&lt;span&gt;&#x25cf;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
                        &lt;td style="text-align:justify"&gt;&lt;span style="font-family:Times New Roman, Times, Serif;font-size:10pt"&gt;any other terms of such subscription rights, including exercise, settlement and other procedures and limitations relating to the transfer and exercise of such subscription rights.&lt;/span&gt;&lt;/td&gt;
                      &lt;/tr&gt;
                    
                  &lt;/table&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;Exercise of Subscription Right&lt;/strong&gt;&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;Each subscription right would entitle the holder of the subscription right to purchase for cash such number of shares at such exercise price as in each case is set forth in, or be determinable as set forth in the Prospectus Supplement relating to the subscription rights offered thereby. Subscription rights would be exercisable at any time up to the close of business on the expiration date for such subscription rights set forth in the Prospectus Supplement. After the close of business on the expiration date, all unexercised subscription rights would become void.&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;Upon expiration of the rights offering and the receipt of payment and the subscription rights certificate properly completed and duly executed at the corporate trust office of the subscription rights agent or any other office indicated in the Prospectus Supplement, the Fund would issue, as soon as practicable, the shares purchased as a result of such exercise. To the extent permissible under applicable law, the Fund may determine to offer any unsubscribed offered securities directly to persons other than shareholders, to or through agents, underwriters or dealers or through a combination of such methods, as set forth in the applicable Prospectus Supplement.&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&lt;strong&gt;Transferable Rights Offering&lt;/strong&gt;&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0"&gt;&#160;&lt;/p&gt;
                  &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;Subscription rights issued by the Fund may be transferrable. The distribution to shareholders of transferable rights, which may themselves have intrinsic value, also will afford non-participating shareholders the potential of receiving cash payment upon the sale of the rights, receipt of which may be viewed as partial compensation for any dilution of their interests that may occur as a result of the rights offering. In a transferrable rights offering, management of the Fund will use its best efforts to ensure an adequate trading market in the rights for use by shareholders who do not exercise such rights. However, there can be no assurance that a market for transferable rights will develop or, if such a market does develop, what the price of the transferable rights will be. In a transferrable rights offering to purchase Common Shares at a price below NAV, the subscription ratio will not be less than 1-for-3, that is the holders of Common Shares of record on the record date of the rights offering will receive one right for each outstanding Common Share owned on the record date and the rights will entitle their holders to purchase one new Common Share for every three rights held (provided that any Common Shareholder who owns fewer than three Common Shares as of the record date may subscribe for one full Common Share). Assuming the exercise of all rights, such a rights offering would result in an approximately 33 1&#x2044;3% increase in the Fund&#x2019;s Common Shares outstanding.&lt;/p&gt;
                &lt;/div&gt;
              
              &lt;div style="display:none"&gt;
                
                  &lt;div&gt;&#160;&lt;/div&gt;
                
              &lt;/div&gt;
            &lt;/div&gt;
          
              &lt;div&gt;&#160;&lt;/div&gt;
            
                &lt;p style="font:10pt Times New Roman, Times, Serif;margin:0pt 0;text-align:justify"&gt;&lt;i&gt;Additional Information on the Transferability of Rights.&lt;/i&gt; &#160;The staff of the SEC has interpreted the 1940 Act as not requiring shareholder approval of a transferable rights offering to purchase Common Shares at a price below the then current NAV so long as certain conditions are met, including: (i)&#160;a good faith determination by a fund's board that such offering would result in a net benefit to existing shareholders; (ii)&#160;the offering fully protects shareholders' preemptive rights and does not discriminate among shareholders (except for the possible effect of not offering fractional Rights); (iii)&#160;management uses its best efforts to ensure an adequate trading market in the rights for use by shareholders who do not exercise such rights; and (iv)&#160;the ratio of a transferable rights offering does not exceed one new share for each three rights held.&lt;/p&gt;
              </cef:OtherSecurityDescriptionTextBlock>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fxbrl_20260807123749016"
          xlink:label="Fxbrl_20260807123749016"
          xlink:type="locator"/>
        <link:footnote id="FN20260807124034952" xlink:label="FN20260807124034952" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Principal amount outstanding represents the principal amount owed by the Fund to lenders under the line of credit in place at the time.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807123749016"
          xlink:to="FN20260807124034952"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807123800655"
          xlink:label="Fxbrl_20260807123800655"
          xlink:type="locator"/>
        <link:footnote id="FN20260807124058669" xlink:label="FN20260807124058669" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Asset coverage per $1,000 is calculated by dividing total assets (less all liabilities and indebtedness not represented by senior securities) by the amount of the line of credit outstanding and then multiplying by $1,000.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807123800655"
          xlink:to="FN20260807124058669"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807123853555"
          xlink:label="Fxbrl_20260807123853555"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807123853555"
          xlink:to="FN20260807124034952"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807123856018"
          xlink:label="Fxbrl_20260807123856018"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807123856018"
          xlink:to="FN20260807124034952"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807123858754"
          xlink:label="Fxbrl_20260807123858754"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807123858754"
          xlink:to="FN20260807124034952"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807123901695"
          xlink:label="Fxbrl_20260807123901695"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807123901695"
          xlink:to="FN20260807124034952"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807123904348"
          xlink:label="Fxbrl_20260807123904348"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807123904348"
          xlink:to="FN20260807124034952"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807123906989"
          xlink:label="Fxbrl_20260807123906989"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807123906989"
          xlink:to="FN20260807124034952"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807123913456"
          xlink:label="Fxbrl_20260807123913456"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807123913456"
          xlink:to="FN20260807124034952"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807123920718"
          xlink:label="Fxbrl_20260807123920718"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807123920718"
          xlink:to="FN20260807124034952"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807123925358"
          xlink:label="Fxbrl_20260807123925358"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807123925358"
          xlink:to="FN20260807124034952"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807123957392"
          xlink:label="Fxbrl_20260807123957392"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807123957392"
          xlink:to="FN20260807124058669"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807124000397"
          xlink:label="Fxbrl_20260807124000397"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807124000397"
          xlink:to="FN20260807124058669"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807124003005"
          xlink:label="Fxbrl_20260807124003005"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807124003005"
          xlink:to="FN20260807124058669"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807124005867"
          xlink:label="Fxbrl_20260807124005867"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807124005867"
          xlink:to="FN20260807124058669"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807124009416"
          xlink:label="Fxbrl_20260807124009416"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807124009416"
          xlink:to="FN20260807124058669"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807124012460"
          xlink:label="Fxbrl_20260807124012460"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807124012460"
          xlink:to="FN20260807124058669"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807124015728"
          xlink:label="Fxbrl_20260807124015728"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807124015728"
          xlink:to="FN20260807124058669"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807124019244"
          xlink:label="Fxbrl_20260807124019244"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807124019244"
          xlink:to="FN20260807124058669"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807124022681"
          xlink:label="Fxbrl_20260807124022681"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807124022681"
          xlink:to="FN20260807124058669"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807124025301"
          xlink:label="Fxbrl_20260807124025301"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807124025301"
          xlink:to="FN20260807124058669"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807125145440"
          xlink:label="Fxbrl_20260807125145440"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807125145440"
          xlink:to="FN20260807124034952"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807121100687"
          xlink:label="Fxbrl_20260807121100687"
          xlink:type="locator"/>
        <link:footnote id="FN20260807122037187" xlink:label="FN20260807122037187" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">If Common Shares are sold to or through underwriters, a prospectus supplement will set forth any applicable sales load and the estimated offering expenses borne by the Fund.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807121100687"
          xlink:to="FN20260807122037187"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807121104578"
          xlink:label="Fxbrl_20260807121104578"
          xlink:type="locator"/>
        <link:footnote id="FN20260807122057388" xlink:label="FN20260807122057388" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Offering expenses payable by the Fund will be deducted from the proceeds, before expenses, to the Fund.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807121104578"
          xlink:to="FN20260807122057388"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807121145562"
          xlink:label="Fxbrl_20260807121145562"
          xlink:type="locator"/>
        <link:footnote id="FN20260807122121584" xlink:label="FN20260807122121584" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Shareholders who participate in the Fund&#x2019;s Dividend Reinvestment and Optional Cash Purchase Plan (the &#x201c;Plan&#x201d;) may be subject to fees on certain transactions. The Plan Agent's (as defined under &#x201c;Dividend Reinvestment and Optional Cash Purchase Plan&#x201d; in this Prospectus) fees for the handling of the reinvestment of dividends will be paid by the Fund; however, participating shareholders will pay a $0.02 per share fee incurred in connection with open-market purchases in connection with the reinvestment of dividends, capital gains distributions and voluntary cash payments made by the participant, which will be deducted from the value of the dividend. For optional share purchases, shareholders will also be charged a $2.50 fee for automatic debits from a checking/savings account, a $5.00 one-time fee for online bank debit and/or $5.00 for check. Shareholders will be subject to $0.12 per share fee and either a $10.00 fee (for batch orders) or $25.00 fee (for market orders) for sales of shares held in a dividend reinvestment account. Per share fees include any applicable brokerage commissions the Plan agent is required to pay. For more details about the Plan, see &#x201c;Dividend Reinvestment and Optional Cash Purchase Plan&#x201d; in this Prospectus.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807121145562"
          xlink:to="FN20260807122121584"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807121149694"
          xlink:label="Fxbrl_20260807121149694"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807121149694"
          xlink:to="FN20260807122121584"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807121155059"
          xlink:label="Fxbrl_20260807121155059"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807121155059"
          xlink:to="FN20260807122121584"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807121158593"
          xlink:label="Fxbrl_20260807121158593"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807121158593"
          xlink:to="FN20260807122121584"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807121536666"
          xlink:label="Fxbrl_20260807121536666"
          xlink:type="locator"/>
        <link:footnote id="FN20260807122150498" xlink:label="FN20260807122150498" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Adviser receives an annual investment advisory fee of 1.00% based on the Fund&#x2019;s average daily managed assets, computed daily and payable monthly. &#x201c;Managed Assets&#x201d; means total assets of the Fund, including any form of investment leverage, minus all accrued expenses incurred in the normal course of operations, but not excluding any liabilities or obligations attributable to investment leverage obtained through (i) indebtedness of any type (including, without limitation, borrowing through a credit facility or the issuance of debt securities), (ii) the issuance of preferred stock or other similar preference securities, (iii) the reinvestment of collateral received for securities loaned in accordance with the Fund&#x2019;s investment objectives and policies, and/or (iv) any other means.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807121536666"
          xlink:to="FN20260807122150498"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807121605354"
          xlink:label="Fxbrl_20260807121605354"
          xlink:type="locator"/>
        <link:footnote id="FN20260807122211443" xlink:label="FN20260807122211443" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The percentage in the table is based on average total borrowings of $4,704,454 (the average balance outstanding under the Fund&#x2019;s secured, uncommitted line of credit with BNP Paribas Prime Brokerage International Ltd. (the &#x201c;Credit Facility&#x201d;) during the period ended April 30, 2026, representing approximately 0.4% of the Fund&#x2019;s total average assets, which includes the assets purchased through leverage) and an average interest rate during the six months ended April 30, 2026, of 4.82%. There can be no assurances that the Fund will be able to obtain such level of borrowing (or to maintain its current level of borrowing), that the terms under which the Fund borrows will not change, or that the Fund&#x2019;s use of leverage will be profitable. The Fund currently intends during the next twelve months to maintain a similar proportionate amount of borrowings but may increase such amount to 33 1/3% of the average daily value of the Fund&#x2019;s total assets.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807121605354"
          xlink:to="FN20260807122211443"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807133254950"
          xlink:label="Fxbrl_20260807133254950"
          xlink:type="locator"/>
        <link:footnote id="FN20260807143646546" xlink:label="FN20260807143646546" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Beginning with the year ended October 31, 2018, the Fund has been audited by KPMG LLP. Previous years were audited by a different independent registered public accounting firm.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807133254950"
          xlink:to="FN20260807143646546"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807133541876"
          xlink:label="Fxbrl_20260807133541876"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807133541876"
          xlink:to="FN20260807143646546"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807133815453_xbrl_20260807133635122_xbrl_20260807133230859"
          xlink:label="Fxbrl_20260807133815453_xbrl_20260807133635122_xbrl_20260807133230859"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807133815453_xbrl_20260807133635122_xbrl_20260807133230859"
          xlink:to="FN20260807143646546"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807133940175_xbrl_20260807133635122_xbrl_20260807133230859"
          xlink:label="Fxbrl_20260807133940175_xbrl_20260807133635122_xbrl_20260807133230859"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807133940175_xbrl_20260807133635122_xbrl_20260807133230859"
          xlink:to="FN20260807143646546"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807133948241_xbrl_20260807133635122_xbrl_20260807133236731"
          xlink:label="Fxbrl_20260807133948241_xbrl_20260807133635122_xbrl_20260807133236731"
          xlink:type="locator"/>
        <link:footnote id="FN20260807143526367" xlink:label="FN20260807143526367" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Asset coverage per $1,000 is calculated by dividing total assets (less all liabilities and indebtedness not represented by senior securities) by the amount of the line of credit and then multiplying by $1,000.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807133948241_xbrl_20260807133635122_xbrl_20260807133236731"
          xlink:to="FN20260807143526367"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807133948241_xbrl_20260807133635122_xbrl_20260807133233581"
          xlink:label="Fxbrl_20260807133948241_xbrl_20260807133635122_xbrl_20260807133233581"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807133948241_xbrl_20260807133635122_xbrl_20260807133233581"
          xlink:to="FN20260807143526367"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807133948241_xbrl_20260807133635122_xbrl_20260807133230859"
          xlink:label="Fxbrl_20260807133948241_xbrl_20260807133635122_xbrl_20260807133230859"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807133948241_xbrl_20260807133635122_xbrl_20260807133230859"
          xlink:to="FN20260807143526367"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807133948241_xbrl_20260807133635122_xbrl_20260807133228067"
          xlink:label="Fxbrl_20260807133948241_xbrl_20260807133635122_xbrl_20260807133228067"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807133948241_xbrl_20260807133635122_xbrl_20260807133228067"
          xlink:to="FN20260807143526367"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807133948241_xbrl_20260807133635122_xbrl_20260807132313193"
          xlink:label="Fxbrl_20260807133948241_xbrl_20260807133635122_xbrl_20260807132313193"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807133948241_xbrl_20260807133635122_xbrl_20260807132313193"
          xlink:to="FN20260807143526367"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807133948241_xbrl_20260807133644308"
          xlink:label="Fxbrl_20260807133948241_xbrl_20260807133644308"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807133948241_xbrl_20260807133644308"
          xlink:to="FN20260807143526367"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141419927_xbrl_20260807133916328_xbrl_20260807133635122_xbrl_20260807133230859"
          xlink:label="Fxbrl_20260807141419927_xbrl_20260807133916328_xbrl_20260807133635122_xbrl_20260807133230859"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141419927_xbrl_20260807133916328_xbrl_20260807133635122_xbrl_20260807133230859"
          xlink:to="FN20260807143646546"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807140451982"
          xlink:label="Fxbrl_20260807140451982"
          xlink:type="locator"/>
        <link:footnote id="FN20260807151833579" xlink:label="FN20260807151833579" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Source: Bloomberg L.P.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807140451982"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnote id="FN20260807165018718" xlink:label="FN20260807165018718" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Data presented are with respect to a short period of time and are not indicative of future performance.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807140451982"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807140508176"
          xlink:label="Fxbrl_20260807140508176"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807140508176"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807140508176"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807140614668"
          xlink:label="Fxbrl_20260807140614668"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807140614668"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807140614668"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807140629332"
          xlink:label="Fxbrl_20260807140629332"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807140629332"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807140629332"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807140802003"
          xlink:label="Fxbrl_20260807140802003"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807140802003"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807140802003"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807140842296"
          xlink:label="Fxbrl_20260807140842296"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807140842296"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807140842296"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141309538_xbrl_20260807140842296"
          xlink:label="Fxbrl_20260807141309538_xbrl_20260807140842296"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141309538_xbrl_20260807140842296"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141309538_xbrl_20260807140842296"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141309538_xbrl_20260807140802003"
          xlink:label="Fxbrl_20260807141309538_xbrl_20260807140802003"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141309538_xbrl_20260807140802003"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141309538_xbrl_20260807140802003"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141309538_xbrl_20260807140629332"
          xlink:label="Fxbrl_20260807141309538_xbrl_20260807140629332"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141309538_xbrl_20260807140629332"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141309538_xbrl_20260807140629332"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141309538_xbrl_20260807140614668"
          xlink:label="Fxbrl_20260807141309538_xbrl_20260807140614668"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141309538_xbrl_20260807140614668"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141309538_xbrl_20260807140614668"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141309538_xbrl_20260807140508176"
          xlink:label="Fxbrl_20260807141309538_xbrl_20260807140508176"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141309538_xbrl_20260807140508176"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141309538_xbrl_20260807140508176"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141309538_xbrl_20260807140451982"
          xlink:label="Fxbrl_20260807141309538_xbrl_20260807140451982"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141309538_xbrl_20260807140451982"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141309538_xbrl_20260807140451982"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141325994_xbrl_20260807140842296"
          xlink:label="Fxbrl_20260807141325994_xbrl_20260807140842296"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141325994_xbrl_20260807140842296"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141325994_xbrl_20260807140842296"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141325994_xbrl_20260807140802003"
          xlink:label="Fxbrl_20260807141325994_xbrl_20260807140802003"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141325994_xbrl_20260807140802003"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141325994_xbrl_20260807140802003"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141325994_xbrl_20260807140629332"
          xlink:label="Fxbrl_20260807141325994_xbrl_20260807140629332"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141325994_xbrl_20260807140629332"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141325994_xbrl_20260807140629332"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141325994_xbrl_20260807140614668"
          xlink:label="Fxbrl_20260807141325994_xbrl_20260807140614668"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141325994_xbrl_20260807140614668"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141325994_xbrl_20260807140614668"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141325994_xbrl_20260807140508176"
          xlink:label="Fxbrl_20260807141325994_xbrl_20260807140508176"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141325994_xbrl_20260807140508176"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141325994_xbrl_20260807140508176"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141325994_xbrl_20260807140451982"
          xlink:label="Fxbrl_20260807141325994_xbrl_20260807140451982"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141325994_xbrl_20260807140451982"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141325994_xbrl_20260807140451982"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141327779_xbrl_20260807140842296"
          xlink:label="Fxbrl_20260807141327779_xbrl_20260807140842296"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141327779_xbrl_20260807140842296"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141327779_xbrl_20260807140842296"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141327779_xbrl_20260807140802003"
          xlink:label="Fxbrl_20260807141327779_xbrl_20260807140802003"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141327779_xbrl_20260807140802003"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141327779_xbrl_20260807140802003"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141327779_xbrl_20260807140629332"
          xlink:label="Fxbrl_20260807141327779_xbrl_20260807140629332"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141327779_xbrl_20260807140629332"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141327779_xbrl_20260807140629332"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141327779_xbrl_20260807140614668"
          xlink:label="Fxbrl_20260807141327779_xbrl_20260807140614668"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141327779_xbrl_20260807140614668"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141327779_xbrl_20260807140614668"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141327779_xbrl_20260807140508176"
          xlink:label="Fxbrl_20260807141327779_xbrl_20260807140508176"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141327779_xbrl_20260807140508176"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141327779_xbrl_20260807140508176"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141327779_xbrl_20260807140451982"
          xlink:label="Fxbrl_20260807141327779_xbrl_20260807140451982"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141327779_xbrl_20260807140451982"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141327779_xbrl_20260807140451982"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141329494_xbrl_20260807140842296"
          xlink:label="Fxbrl_20260807141329494_xbrl_20260807140842296"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141329494_xbrl_20260807140842296"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141329494_xbrl_20260807140842296"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141329494_xbrl_20260807140802003"
          xlink:label="Fxbrl_20260807141329494_xbrl_20260807140802003"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141329494_xbrl_20260807140802003"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141329494_xbrl_20260807140802003"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141329494_xbrl_20260807140629332"
          xlink:label="Fxbrl_20260807141329494_xbrl_20260807140629332"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141329494_xbrl_20260807140629332"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141329494_xbrl_20260807140629332"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141329494_xbrl_20260807140614668"
          xlink:label="Fxbrl_20260807141329494_xbrl_20260807140614668"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141329494_xbrl_20260807140614668"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141329494_xbrl_20260807140614668"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141329494_xbrl_20260807140508176"
          xlink:label="Fxbrl_20260807141329494_xbrl_20260807140508176"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141329494_xbrl_20260807140508176"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141329494_xbrl_20260807140508176"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141329494_xbrl_20260807140451982"
          xlink:label="Fxbrl_20260807141329494_xbrl_20260807140451982"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141329494_xbrl_20260807140451982"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141329494_xbrl_20260807140451982"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141331229_xbrl_20260807140842296"
          xlink:label="Fxbrl_20260807141331229_xbrl_20260807140842296"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141331229_xbrl_20260807140842296"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141331229_xbrl_20260807140842296"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141331229_xbrl_20260807140802003"
          xlink:label="Fxbrl_20260807141331229_xbrl_20260807140802003"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141331229_xbrl_20260807140802003"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141331229_xbrl_20260807140802003"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141331229_xbrl_20260807140629332"
          xlink:label="Fxbrl_20260807141331229_xbrl_20260807140629332"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141331229_xbrl_20260807140629332"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141331229_xbrl_20260807140629332"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141331229_xbrl_20260807140614668"
          xlink:label="Fxbrl_20260807141331229_xbrl_20260807140614668"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141331229_xbrl_20260807140614668"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141331229_xbrl_20260807140614668"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141331229_xbrl_20260807140508176"
          xlink:label="Fxbrl_20260807141331229_xbrl_20260807140508176"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141331229_xbrl_20260807140508176"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141331229_xbrl_20260807140508176"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141331229_xbrl_20260807140451982"
          xlink:label="Fxbrl_20260807141331229_xbrl_20260807140451982"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141331229_xbrl_20260807140451982"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141331229_xbrl_20260807140451982"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141338373_xbrl_20260807140842296"
          xlink:label="Fxbrl_20260807141338373_xbrl_20260807140842296"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141338373_xbrl_20260807140842296"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141338373_xbrl_20260807140842296"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141338373_xbrl_20260807140802003"
          xlink:label="Fxbrl_20260807141338373_xbrl_20260807140802003"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141338373_xbrl_20260807140802003"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141338373_xbrl_20260807140802003"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141338373_xbrl_20260807140629332"
          xlink:label="Fxbrl_20260807141338373_xbrl_20260807140629332"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141338373_xbrl_20260807140629332"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141338373_xbrl_20260807140629332"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141338373_xbrl_20260807140614668"
          xlink:label="Fxbrl_20260807141338373_xbrl_20260807140614668"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141338373_xbrl_20260807140614668"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141338373_xbrl_20260807140614668"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141338373_xbrl_20260807140508176"
          xlink:label="Fxbrl_20260807141338373_xbrl_20260807140508176"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141338373_xbrl_20260807140508176"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141338373_xbrl_20260807140508176"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141338373_xbrl_20260807140451982"
          xlink:label="Fxbrl_20260807141338373_xbrl_20260807140451982"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141338373_xbrl_20260807140451982"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141338373_xbrl_20260807140451982"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141341787_xbrl_20260807140842296"
          xlink:label="Fxbrl_20260807141341787_xbrl_20260807140842296"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141341787_xbrl_20260807140842296"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141341787_xbrl_20260807140842296"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141341787_xbrl_20260807140802003"
          xlink:label="Fxbrl_20260807141341787_xbrl_20260807140802003"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141341787_xbrl_20260807140802003"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141341787_xbrl_20260807140802003"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141341787_xbrl_20260807140629332"
          xlink:label="Fxbrl_20260807141341787_xbrl_20260807140629332"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141341787_xbrl_20260807140629332"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141341787_xbrl_20260807140629332"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141341787_xbrl_20260807140614668"
          xlink:label="Fxbrl_20260807141341787_xbrl_20260807140614668"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141341787_xbrl_20260807140614668"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141341787_xbrl_20260807140614668"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141341787_xbrl_20260807140508176"
          xlink:label="Fxbrl_20260807141341787_xbrl_20260807140508176"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141341787_xbrl_20260807140508176"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141341787_xbrl_20260807140508176"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141341787_xbrl_20260807140451982"
          xlink:label="Fxbrl_20260807141341787_xbrl_20260807140451982"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141341787_xbrl_20260807140451982"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141341787_xbrl_20260807140451982"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141343587_xbrl_20260807140842296"
          xlink:label="Fxbrl_20260807141343587_xbrl_20260807140842296"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141343587_xbrl_20260807140842296"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141343587_xbrl_20260807140842296"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141343587_xbrl_20260807140802003"
          xlink:label="Fxbrl_20260807141343587_xbrl_20260807140802003"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141343587_xbrl_20260807140802003"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141343587_xbrl_20260807140802003"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141343587_xbrl_20260807140629332"
          xlink:label="Fxbrl_20260807141343587_xbrl_20260807140629332"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141343587_xbrl_20260807140629332"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141343587_xbrl_20260807140629332"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141343587_xbrl_20260807140614668"
          xlink:label="Fxbrl_20260807141343587_xbrl_20260807140614668"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141343587_xbrl_20260807140614668"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141343587_xbrl_20260807140614668"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141343587_xbrl_20260807140508176"
          xlink:label="Fxbrl_20260807141343587_xbrl_20260807140508176"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141343587_xbrl_20260807140508176"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141343587_xbrl_20260807140508176"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141343587_xbrl_20260807140451982"
          xlink:label="Fxbrl_20260807141343587_xbrl_20260807140451982"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141343587_xbrl_20260807140451982"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141343587_xbrl_20260807140451982"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141345509_xbrl_20260807140842296"
          xlink:label="Fxbrl_20260807141345509_xbrl_20260807140842296"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141345509_xbrl_20260807140842296"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141345509_xbrl_20260807140842296"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141345509_xbrl_20260807140802003"
          xlink:label="Fxbrl_20260807141345509_xbrl_20260807140802003"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141345509_xbrl_20260807140802003"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141345509_xbrl_20260807140802003"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141345509_xbrl_20260807140629332"
          xlink:label="Fxbrl_20260807141345509_xbrl_20260807140629332"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141345509_xbrl_20260807140629332"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141345509_xbrl_20260807140629332"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141345509_xbrl_20260807140614668"
          xlink:label="Fxbrl_20260807141345509_xbrl_20260807140614668"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141345509_xbrl_20260807140614668"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141345509_xbrl_20260807140614668"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141345509_xbrl_20260807140508176"
          xlink:label="Fxbrl_20260807141345509_xbrl_20260807140508176"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141345509_xbrl_20260807140508176"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141345509_xbrl_20260807140508176"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141345509_xbrl_20260807140451982"
          xlink:label="Fxbrl_20260807141345509_xbrl_20260807140451982"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141345509_xbrl_20260807140451982"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141345509_xbrl_20260807140451982"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141348066_xbrl_20260807140842296"
          xlink:label="Fxbrl_20260807141348066_xbrl_20260807140842296"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141348066_xbrl_20260807140842296"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141348066_xbrl_20260807140842296"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141348066_xbrl_20260807140802003"
          xlink:label="Fxbrl_20260807141348066_xbrl_20260807140802003"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141348066_xbrl_20260807140802003"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141348066_xbrl_20260807140802003"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141348066_xbrl_20260807140629332"
          xlink:label="Fxbrl_20260807141348066_xbrl_20260807140629332"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141348066_xbrl_20260807140629332"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141348066_xbrl_20260807140629332"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141348066_xbrl_20260807140614668"
          xlink:label="Fxbrl_20260807141348066_xbrl_20260807140614668"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141348066_xbrl_20260807140614668"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141348066_xbrl_20260807140614668"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141348066_xbrl_20260807140508176"
          xlink:label="Fxbrl_20260807141348066_xbrl_20260807140508176"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141348066_xbrl_20260807140508176"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141348066_xbrl_20260807140508176"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fxbrl_20260807141348066_xbrl_20260807140451982"
          xlink:label="Fxbrl_20260807141348066_xbrl_20260807140451982"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141348066_xbrl_20260807140451982"
          xlink:to="FN20260807151833579"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fxbrl_20260807141348066_xbrl_20260807140451982"
          xlink:to="FN20260807165018718"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
